fluorodeoxyglucose f18 has been researched along with Recrudescence in 482 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (3.11) | 18.2507 |
| 2000's | 129 (26.76) | 29.6817 |
| 2010's | 296 (61.41) | 24.3611 |
| 2020's | 42 (8.71) | 2.80 |
| Authors | Studies |
|---|---|
| Appelbaum, J; Bhan, A; Bogun, FM; Chicos, AB; Crawford, TC; Dickfeld, T; Eagle, KA; Ellenbogen, KA; Froehlich, J; Hoogendoorn, JC; Kapa, S; Kim, HM; Kron, J; Mankad, P; Marchlinski, FE; Murgatroyd, F; Muser, D; Narasimhan, C; Patton, KK; Robinson, MR; Rosenthal, DG; Roukoz, H; Sacher, F; Santangeli, P; Sauer, WH; Siontis, KC; Soejima, K; Vedantham, V; Zeppenfeld, K; Zipse, MM | 1 |
| Besutti, G; Boiardi, L; Casali, M; Galli, E; Giorgi Rossi, P; Mancuso, P; Marvisi, C; Muratore, F; Salvarani, C; Spaggiari, L; Versari, A | 1 |
| Du, R; Fang, H; Guo, F; Han, J; Kang, J; Lu, Z; Song, Q | 1 |
| Feng, L; Lu, X; Wang, W; Yang, J; Yang, X | 1 |
| Kuroda, A; Shimizu, M; Shinagawa, A; Suyama, T; Yamamoto, R; Yoshizawa, Y | 1 |
| Benali, K; Eshagh, D; Mageau, A; Papo, T; Sacre, K | 1 |
| Aren, E; Berry, M; Deshpande, S; Estall, V; Fowler, A; Jameson, MG; Johnston, M; Lee, M; Trada, Y | 1 |
| Ashwathanarayana, AG; Bansal, H; Dewangan, V; Goyal, V | 1 |
| Azamat, S; Bulut, MT; Keskin, M; Kulle, CB; Omarov, N; Ozkan, ZG; Uymaz, DS | 1 |
| Akagi, S; Hashimoto, M; Hiraki, T; Ihara, H; Maeda, N; Noma, K; Sugiyama, S; Takao, S; Tanabe, S; Yoshio, K | 1 |
| Brose, A; Eschmann, SM; König, J; Michalski, K; Miederer, M; Nestle, U; Ruf, J; Schreckenberger, M; Tosch, M | 1 |
| Deconinck, L; Duval, X; Iung, B; Mahida, B; Régis, C; Rouzet, F; Thy, M; Tubiana, S | 1 |
| Abdel-Wahab, O; Diamond, EL; Durham, BH; Francis, JH; Lacouture, ME; Panageas, KS; Petrova-Drus, K; Rampal, RK; Reiner, AS; Rotemberg, V; Yabe, M | 1 |
| Bernsdorf, M; Friborg, J; Gothelf, A; Håkansson, K; Kristensen, CA; Lindegaard, AM; Specht, L; Vogelius, I | 1 |
| Adedjouma, A; Buvat, I; Fain, O; Laurent, C; Mekinian, A; Ricard, L; Soussan, M | 1 |
| Cui, Y; Ji, Y; Shao, C; Shao, G; Zheng, J | 1 |
| Benn, BS; De Marco, T; Gerstenfeld, EP; Hsia, HH; Janmohamed, M; Klein, L; Koth, LL; Lee, BK; Moss, JD; Murray, TO; Pampaloni, MH; Parwani, P; Petek, BJ; Rosenthal, DG; Scheinman, MM; Selby, V; Vedantham, V; Zikherman, J | 1 |
| Albert, NL; Bartenstein, P; Brendel, M; Cyran, CC; Herms, J; Ruf, V; Schüller, U; Thon, N; Tonn, JC; Unterrainer, M | 1 |
| Arshad, MA; Barwick, TD; Gandy, N; Park, WE; Rockall, AG | 1 |
| Mountz, JM; Muthukrishnan, A; Nguyen, NC | 1 |
| Fukumi, T; Ishikawa, T; Makita, M; Moriyama, T; Murakami, H; Nagakita, K; Shinno, Y; Sunami, K; Yoshioka, T | 1 |
| Avanzi, GC; Bellan, M; Castello, L; Croce, A; Gavelli, F; Orsini, F; Pedrazzoli, R; Pirisi, M; Puta, E; Sacchetti, GM; Sainaghi, PP; Soddu, D; Sola, D; Zecca, E | 1 |
| Dominguez, ML; Fernandez Llana, B; Gonzalez, FM; Martin, N; Rodriguez Fonseca, OD; Suarez, JP; Vigil, C | 1 |
| Gu, B; Ma, G; Shi, L; Song, S; Yang, Z; Zhang, J; Zhang, Y | 1 |
| Bailey, E; Brewer, J; Fraser, CL; Hsiao, E; Janssen, B; Laurent, R; Nguyen, K; Sammel, AM; Schembri, G; Schrieber, L; Youssef, P | 1 |
| Arraes, AED; Castro, MF; de Souza, AWS; Janes, ALF; Sato, EI; Savioli, B | 1 |
| Alper, E; Belge, G; Bilgin, C; Kandemirli, SG; Ozkaya, G | 1 |
| Amaddeo, G; Calderaro, J; Chalaye, J; Galletto Pregliasco, A; Itti, E; Kharrat, R; Kobeiter, H; Laurent, A; Legou, F; Luciani, A; Mulé, S; Regnault, H; Tacher, V; Tenenhaus, A | 1 |
| Cervati, V; Diegoli, M; Fanti, S; Golfieri, R; Monteduro, F; Mosconi, C; Zanoni, L | 1 |
| Kamada, H; Saito, M; Takanami, K; Takase, K; Toyama, Y | 1 |
| Kidson-Gerber, G; Shuttleworth, C; Thompson, SR; Wegner, EA | 1 |
| Gao, J; Lin, M; Liu, Y; Wang, G; Wu, Y; Xu, B; Yu, H | 1 |
| Bengel, FM; Beutel, G; David, S; Derlin, T; Eder, M; Ganser, A; Koenecke, C; Möhn, N; Ross, TL; Schultze-Florey, C; Skripuletz, T; Werner, RA | 1 |
| Maw, AM; Schembri, GP; Sood, S | 1 |
| Dubruc, E; Fernandes Vieira, V; Meyer, M; Prior, JO; Raffoul, W | 1 |
| Malik, D | 1 |
| Coutinho, AM; de Andrade, DC; de Lima, LGCA; de Souza Godoy, LF; Pimentel, GA | 1 |
| Qiao, W; Sun, N; Wang, T; Xing, Y; Yang, J; Zhao, J | 1 |
| Cortés-Romera, M; Mestres-Martí, J; Robles-Barba, JJ; Sabaté-Llobera, A; Soldevila-Lozano, C | 1 |
| Al-Yousef, A; Arakelyan, VS; Aslanidis, IP; Belov, YV; Ekaeva, IV; Garmanov, SV; Golukhova, EZ; Kosenkov, AN; Mironenko, VA; Mukhortova, OV; Popov, DA; Pursanova, DM; Shurupova, IV; Vinokurov, IA | 1 |
| Ando, K; Fukushima, K; Hagiwara, N; Imamura, Y; Momose, M; Nagao, M; Nakao, R; Sakai, A; Sakai, S; Suzuki, A; Watanabe, E; Yamamoto, A | 1 |
| Bhattacharya, A; Krishnaraju, VS; Kumar, R; Mittal, BR; Patro, SK; Singh, H | 1 |
| Kuang, A; Shen, G; Wang, R | 1 |
| Altino de Almeida, S; Cardoso, FR; Carvalho, ARS; Gonçalves Martins, PA; Mattos, RSAR; Nigri, DH; Rodrigues, RS; Rosado-de-Castro, PH; Stasiak, CES | 1 |
| Chen, BX; Liu, X; Nanna, M; Shi, L; Wang, Y; Wu, JY; Xie, B; Yang, MF; Yang, X; Zeng, L; Zhou, Y | 1 |
| Hotta, M; Minamimoto, R; Suzuki, D; Takahashi, A | 1 |
| Fellner, FA; Gabriel, M; Hatzl, M; Röper-Kelmayr, JC | 1 |
| Zheng, K; Zhuang, H | 1 |
| Coy, JF | 1 |
| Avivi, I; Bar-Shalom, R; Benyamini, N; Dann, EJ; Farbstein, D; Lavi, N; Shapira, G; Zilberlicht, A | 1 |
| Bhartia, S; Sharma, P | 1 |
| Lu, Y; Sanan, P | 1 |
| Adams, HJA; Kwee, TC | 1 |
| Frary, EC; Gerke, O; Hess, S; Laustrup, H | 1 |
| Jinguji, M; Kajiya, Y; Kitazono, M; Nakajo, M; Tani, A; Yoshiura, T | 1 |
| He, Q; Shi, X; Wang, X; Zhang, B; Zhang, X | 1 |
| Bailly, P; Bouzerar, R; Daouk, J; Meyer, ME; Shields, T | 1 |
| Higuchi, T; Kitajima, K; Miyoshi, Y; Odawara, S; Yamakado, K; Yamano, T | 1 |
| Amthauer, H; Denecke, T; Dreyling, MH; Franzius, C; Kneba, M; Reinke, P; Riess, H; Subklewe, M; Trappe, RU; Zimmermann, H | 1 |
| Anconina, R; Ezroh Kazap, D; Hod, N; Lantsberg, S; Levin, D | 1 |
| Ammari, S; Danu, A; Dercle, L; Houot, R; Labaied, N; Lazarovici, J; Marabelle, A; Michot, JM; Mokrane, FZ; Ribrag, V; Schwartz, LH; Seban, RD | 1 |
| Amano, K; Fukuchi, M; Ishida, H; Ishiguro, T; Ito, T; Kumakura, M; Mochiki, E; Muta, Y; Ogura, T; Yamamoto, A | 1 |
| Dirksen, U; Heinemann, M; Jürgens, H; Langer, T; Ranft, A; Stegger, L; Timmermann, B; Vieth, V; Weckesser, M | 1 |
| Pan, C; Xie, D; Xu, Y; Yu, W; Zheng, M | 1 |
| Borde, CR; Palaniswamy, SS; Subramanyam, P | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Kim, BT; Kim, SJ; Lee, KH; Moon, SH; Shim, YM; Yi, HK | 1 |
| Hosoya, K; Ishibashi, M; Kaida, H; Kinoshita, T; Kitajima, K; Miyoshi, Y; Morita, T; Nakajo, M; Nakatani, K; Tani, A; Yamaguchi, K | 1 |
| Alexandra, JF; Benali, K; Ducrocq, G; Gerardin, C; Jouan, F; Mageau, A; Papo, T; Sacre, K; van Gysel, D | 1 |
| Cui, Y; Czito, BG; Das, S; Eng, JS; Faught, AM; Higgins, K; Hong, JC; Palta, M; Patel, BN; Rushing, CN; Willett, CG; Yin, FF | 1 |
| Kleynhans, L; Malherbe, ST; Walzl, G | 1 |
| Cheng, J; Feng, Z; Liu, S; Lu, L; Sun, Y; Wang, M; Xu, J; Yuan, H; Zhang, Y | 1 |
| Kumar, R; Mittal, BR; Parihar, AS; Rana, S; Singh, H; Singh, S; Vadi, SK | 1 |
| Hino, A; Ishikawa, J; Kano, R; Masaie, H; Nagata, S; Nakatsuka, SI; Yasuoka, H | 1 |
| Colletti, PM; Marzola, MC; Rubello, D | 1 |
| Chan, D; Fielding, P; Foley, KG; Lewis, WG; Patel, N; Powell, AG; Roberts, SA; Wheat, JR | 1 |
| Bal, A; Basher, RK; Bhattacharya, A; Kapoor, R; Mittal, BR; Parihar, AS; Singh, G; Sood, A; Vadi, SK | 1 |
| Kang, WJ; Kim, HJ; Kim, S; Kim, SW; Kim, YT; Lee, CY; Lee, IO; Lee, JY; Nam, EJ | 1 |
| Bailly, C; Béné, MC; Blin, N; Bodet-Milin, C; Bonnet, A; Bouard, L; Bourgeois, AL; Chevallier, P; Dubruille, V; Garnier, A; Gastinne, T; Gouill, SL; Guillaume, T; Kraeber-Bodéré, F; Lok, A; Mahé, B; Moreau, P; Peterlin, P; Touzeau, C | 1 |
| Ganeshalingam, R; Roach, P; Schembri, GP | 1 |
| Albert, NL; Arbizu, J; Boellaard, R; Drzezga, A; Galldiks, N; la Fougère, C; Langen, KJ; Law, I; Lopci, E; Lowe, V; McConathy, J; Quick, HH; Sattler, B; Schuster, DM; Tonn, JC; Weller, M | 1 |
| Alfieri, J; Bonaffini, PA; Desseroit, MC; Hatt, M; Lucia, F; Masson, I; Mervoyer, A; Miranda, O; Pradier, O; Reinhold, C; Robin, P; Schick, U; Vallières, M; Visvikis, D | 1 |
| Cortés-Romera, M; Cos-Domingo, M; Gámez Cenzano, C; Moreno-Llorente, P; Pérez-Maraver, M; Reynés-Llompart, G; Rodríguez-Bel, L; Rossi-Seoane, S; Sabaté-Llobera, A; Vercher Conejero, JL | 1 |
| Banks, KP; Gusman, M; Peacock, JG; Wickley, AB; Zhao, JM | 1 |
| Wen, Z; Zhuang, H | 1 |
| Matsushima, S; Nishimura, M; Okuyama, C; Yamada, K | 1 |
| Alexandra, JF; Benali, K; Bertinchamp, R; Goulenok, T; Mageau, A; Morin, G; Papo, T; Piekarski, E; Raimbourg, Q; Sacre, K; van Gysel, D | 1 |
| Alavi, A; Castro, SA; Muser, D; Santangeli, P | 1 |
| Chague, P; Cottereau, AS; Lapusan, S; Phan, CM; Zhang-Yin, J | 1 |
| Ahmed, S; Aleman, BMP; Andraos, TY; Balogh, A; Binkley, MS; Brady, JL; Bratman, SV; Chau, K; Chelius, M; Choi, SH; Constine, LS; Dabaja, B; Eich, HT; El-Galaly, TC; Filippi, AR; Hajj, C; Hardy, S; Hodgson, DC; Hoppe, RT; Jones, M; Kirova, YM; Levis, M; MacManus, M; Mikhaeel, NG; Ng, AK; Oguchi, M; Reinartz, G; Ricardi, U; Suh, CO; Vistisen, AK; Wirth, A; Yahalom, J | 1 |
| Brice, P; Casasnovas, O; Chen, A; Dercle, L; Ghesquières, H; Houot, R; Manson, G; Mokrane, FZ; Morschhauser, F; Schiano de Colella, JM; Stamatoullas, A | 1 |
| Appold, S; Bandurska-Luque, A; Hoberück, S; Kohler, A; Kotzerke, J; Löck, S; Schreiber, A; Zips, D; Zöphel, K | 1 |
| Abdalla, A; Ali, I; Molloy, E; Murphy, D | 1 |
| Chang, YH; Ho, KW; Hsu, CC; Huang, YC | 1 |
| Albaghdadi, MS; Berrett, TB; Buscombe, JR; Chowdhury, MM; Coughlin, PA; Dweck, MR; Evans, NR; Hayes, PD; Joshi, FR; Le, EPV; Newby, DE; Rudd, JHF; Sadat, U; Tarkin, JM; Warburton, EA | 1 |
| Ahn, YC; Choi, JY; Hyun, SH; Kim, SJ; Lee, KS; Moon, SH; Oh, D; Shim, YM; Sun, JM; Zo, JI | 1 |
| Bhattacharya, A; Dhir, V; Jain, S; Kumar, R; Mb, A; Mittal, BR; Naidu, GSRSNK; Sharma, A; Sharma, V; Singh, H; Sood, A; Verma, R | 1 |
| Bando-Delaunay, A; Cassou-Mounat, T; Huchet, V; Jehanno, N; Luporsi, M | 1 |
| Cornic, M; Edet-Sanson, A; Laberge-Le Couteulx, S; Lansoy-Kuhn, C; Mechken, F; Picquenot, JM; Vera, P | 1 |
| Bal, C; Kumar, R; Sharma, P; Singh, H; Suman, KC | 1 |
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| Avivi, I; Bar-Shalom, R; Dann, EJ; Faibish, T; Leiba, R; Rowe, JM; Zilberlicht, A | 1 |
| Becker, CD; Becker, M; Dulguerov, P; Lovblad, KO; Masterson, K; Rager, O; Ratib, O; Varoquaux, A | 1 |
| Loock, J; Manger, B | 1 |
| Ceriani, L; Foppiani, L; Giovanella, L; Piccardo, A; Treglia, G; Trimboli, P; Verburg, FA | 1 |
| Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G | 1 |
| Basso, SM; Bertozzi, S; Capobianco, G; Lumachi, F; Pasqual, EM; Re, GL; Santeufemia, DA; Tumolo, S | 1 |
| Barajas, RF; Hernandez-Pampaloni, M; Olorunsola, D; Sugrue, LP; Yu, JP | 1 |
| Hsu, CT; Huang, CC; Huang, HH; Kao, PF; Lee, JK | 1 |
| Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
| Andrade, BB; Cole, S; Hanna, D; Kim, P; Maeurer, M; Schito, M; Wallis, RS; Zumla, A | 1 |
| Bal, C; Jain, TK; Kumar, R; Sahoo, MK; Sharma, P; Suman, S | 1 |
| Choi, CW; Choi, TH; Hwang, JP; Kang, HJ; Kim, BI; Kim, KM; Lee, SS; Lim, I; Lim, SM; Park, JY; Yang, SH | 1 |
| Bakhshi, S; Bal, C; Khan, SA; Khangembam, BC; Kumar, R; Malhotra, A; Rastogi, S; Sharma, P; Singh, H; Suman, KC; Thulkar, S | 1 |
| Dhull, VS; Jain, SK; Kumar, R; Maharjan, S; Malhotra, A; Patel, CD; Sharma, DN; Sharma, P; Thulkar, S | 1 |
| Dietlein, M; Drzezga, A; Kahraman, D; Kobe, C; Kuhnert, G; Rothe, A; Sasse, S; Scheid, C; Theurich, S; von Bergwelt-Baildon, M | 1 |
| Kim, YJ; Lee, DH; Lee, JW; Lee, SM | 1 |
| Shim, KN; Yun, HW | 1 |
| Bargay, J; Bello, JL; Caballero, D; Canales, M; Cortés, M; Donato, E; Ferrer, S; González-Barca, E; Oriol, A; Salar, A; Sánchez, JJ; Tomás, JF; Vidal, MJ | 1 |
| Bandiera, A; Gajate, AM; Gallivanone, F; Gianolli, L; Landoni, C; Melloni, G; Muriana, P; Sestini, S; Zannini, P | 1 |
| Grutters, JC; Keijsers, RG; Rijkers, GT; van Moorsel, CH; Verwoerd, A; Vorselaars, AD | 1 |
| Ahn, BC; Jang, YJ; Jeong, SY; Lee, J; Lee, SW; Park, JY; Son, SH; Song, BI | 1 |
| Bjurberg, M; Brun, E | 1 |
| Chung, SK; Chung, YA; Jeon, HM; Kim, SH; Kim, YS; Oh, JK; Park, YH | 1 |
| Ebina, Y; Hosaka, M; Kaneuchi, M; Kudo, M; Sakuragi, N; Takeda, M; Watari, H; Yamada, H | 1 |
| Couturier, OF; Delva, R; George, A; Girault, S; Morel, O; Soulié, P; Testard, A | 1 |
| Ho, TY; Lee, LY; Liao, CT; Lin, CY; Tseng, JR; Wang, HM; Yen, TC | 1 |
| Gönen, M; Lilienstein, J; Maragulia, J; Moskowitz, CH; Ulaner, GA; Zelenetz, AD | 1 |
| Chen, T; Chen, YM; Shi, YP; Tong, LJ; Wan, LR; Zee, CS | 1 |
| Chu, YK; Li, WY; Yang, RH | 1 |
| Cheon, GJ; Choe, JG; Kim, DS; Oh, SY; Park, BJ; Park, TG; Yu, YD | 1 |
| Davidzon, G; Gevaert, O; Nair, VS; Plevritis, SK; West, R | 1 |
| Eom, HS; Kang, SH; Kim, SK; Kim, TS; Kim, YI; Lee, H; Park, WS; Yun, T | 1 |
| Fukuda, M; Keino, D; Kinoshita, A; Kitagawa, H; Kondoh, K; Morimoto, M; Murata, S; Muto, S; Ohyama, R; Wakisaka, M | 1 |
| Gibbs, RG; Jackson, JE; Mason, JC; Perera, AH; Wolfe, JH; Youngstein, T | 1 |
| Amler, L; Eaton, K; Fine, BM; Gitlitz, B; Hicks, R; Hughes, B; Loecke, D; Mileshkin, L; Mitchell, P; Pirzkall, A; Townley, P; Wood, K | 1 |
| Heusch, P; Lauenstein, TC; Lipponer, C; Nagarajah, J; Nensa, F; Pöppel, TD; Rübben, H; Schlosser, TW; Wetter, A | 1 |
| Beanlands, RS; Birnie, DH; Davis, D; Gollob, MH; Green, M; Healey, JS; Leung, E; McArdle, BA; Nair, GM; Nery, PB; Ohira, H; Yang, J | 1 |
| Altman, JK; Dillehay, GL; Evens, AM; Frankfurt, O; Gentzler, RD; Gordon, LI; Kaminer, L; Mehta, J; Mittal, BB; Petrich, AM; Rademaker, AW; Singhal, S; Variakojis, D; Weitner, BB; Williams, S; Winter, JN | 1 |
| Bamias, A; Datseris, IE; Exarhos, D; Panagiotidis, E; Rondogianni, P; Skilakaki, M; Vlontzou, E | 1 |
| Beckert, S; Claussen, CD; Gatidis, S; Klumpp, B; Koenigsrainer, A; Koenigsrainer, I; Mueller, M; Pfannenberg, C; Schwenzer, NF | 1 |
| Barker, C; Goenka, A; Gonen, M; Kowalski, A; Lim, R; Lovie, S; McCann, P; Schöder, H; Terezakis, SA; Turlakov, A; Yahalom, J | 1 |
| Domènech-Vilardell, A; Ichise, M; Rasiej, MJ; Taub, RN | 1 |
| Berlangieri, S; Eek, R; Murphy, C; Schwalb, H | 1 |
| Cheon, GJ; Chung, HH; Kim, HS; Kim, JW; Park, NH; Song, YS | 1 |
| Brownell, AL; Hara, T; Henke, PK; Hucker, WJ; Jaff, MR; Jaffer, FA; Jokivarsi, K; Kessinger, CW; MacNabb, MH; Tawakol, A; Truelove, J; Weissleder, R; Wojtkiewicz, GR | 1 |
| Gurbani, S; Harper, JS; Jain, SK; Jedynak, BM; Klunk, M; Murawski, AM; Younes, L | 1 |
| Kowalska, A; Lesiak, J; Młynarczyk, J; Trybek, T | 1 |
| Abgral, R; Keromnes, N; Le Roux, PY; Marianowski, R; Palard, X; Potard, G; Robin, P; Rousset, J; Salaun, PY; Valette, G | 1 |
| Bolcaen, J; Boterberg, T; De Vos Pharm, F; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Kalala, JP; Leybaert, L; Van den Broecke, C; Vanhove, C | 1 |
| Buck, AK; Einsele, H; Herrmann, K; Knop, S; Lapa, C; Lückerath, K; Malzahn, U; Samnick, S | 1 |
| Ishiwata, K; Ito, K; Kubota, K; Minamimoto, R; Miyata, Y; Morooka, M; Okasaki, M; Toyohara, J; Yokoyama, J | 1 |
| Bewernick, BH; Hurlemann, R; Kayser, S; Matusch, A; Schlaepfer, TE; Soehle, M | 1 |
| Kang, DW; Kim, HJ; Kim, JS; Kwon, SU; Moon, DH; Oh, M; Yu, KH | 1 |
| Dunleavy, K; Wilson, WH | 1 |
| Cho, A; Chung, KY; Kim, DJ; Lee, CY; Lee, JG; Park, SY; Yu, WS | 1 |
| Cho, YH; Choi, GS; Choi, HJ; Choi, MH; Chung, JC; Jang, JY; Jeong, SW; Jin, SJ; Kim, BS; Kim, DC; Kim, HS; Kim, SG; Kim, YS; Lee, MH; Lee, SH; Lee, YN; Moon, JH; Park, JM; Song, JY | 1 |
| Bal, C; Karunanithi, S; Kumar, R; Murugan, V; Roy, SG | 1 |
| Asman, Y; Even-Sapir, E; Evenson, AR; Shibolet, O | 1 |
| Hoh, CK; Hoshi, H; Kanematsu, M; Kesari, S; Nozawa, A; Piccioni, D; Rivandi, AH | 1 |
| Adachi, S; Akagi, K; Dono, K; Hatano, H; Imamura, H; Iwazawa, T; Komori, T; Masuike, Y; Morita, S; Noda, T; Oshima, K; Tanida, T; Yasumoto, T | 1 |
| Coleman, A; Collins, M; Corry, J; D'Costa, I; De Abreu Lourenco, R; Fua, T; Lau, E; Liu, C; Rischin, D; Shah, K; Te Marvelde, L | 1 |
| Bruno, B; Buttignol, S; Carobolante, F; Cavo, M; Corradini, P; Englaro, E; Fanin, R; Geatti, O; Isola, M; Montefusco, V; Nanni, C; Patriarca, F; Sperotto, A; Stocchi, R; Zamagni, E | 1 |
| Devlin, SM; Hilden, P; Matasar, MJ; Meikle, J; Migliacci, JC; Moskowitz, CH; Sauter, CS; Schoder, H; Ulaner, GA; Zelenetz, AD | 1 |
| Matsusaka, Y; Murakami, K | 1 |
| Paliwal, PR; Sharma, VK; Sinha, AK | 1 |
| Baues, C; Dietlein, M; Eich, HT; Engenhart-Cabillic, R; Engert, A; Haverkamp, H; Haverkamp, U; Hegerfeld, K; Herfarth, K; Kobe, C; Kriz, J; Kuhnert, G; Lukas, P; Reinartz, G; Schmidberger, H; Staar, S | 1 |
| Adams, D; Chahbazian, K; Denier, C; Idbaih, A; Mélé, N; Michot, JM | 1 |
| Barry, CE; Cai, Y; Chen, RY; Dartois, V; Dayao, E; Dodd, LE; England, K; Flynn, JL; Hammoud, D; Herscovitch, P; Richardson, M; Robbins, KK; Schimel, D; Via, LE; Weiner, DM; Zimmerman, MD | 1 |
| Arita, M; Furuta, K; Hotta, M; Ikeda, S; Ikeo, S; Ishida, T; Ito, A; Nishiyama, A | 1 |
| Goense, L; Lam, MG; Meijer, GJ; Reitsma, JB; Ruurda, JP; van Hillegersberg, R; van Rossum, PS; van Vulpen, M | 1 |
| Ahn, SJ; Marashdeh, W; Marcus, C; Subramaniam, RM; Taghipour, M | 1 |
| Deng, H; Jia, Z; Shen, G; Wang, Q; Zhang, W; Zhou, L | 1 |
| Bilfinger, T; Franceschi, D; LoGiurato, B; Matthews, R; Moore, W; Relan, N; Safaie, E | 1 |
| Choi, SH; Kim, JS; Kim, JW; Kim, SY; Nam, SY; Oh, JS; Roh, JL | 1 |
| Cassou-Mounat, T; Cayssials, E; Delwail, V; Puyade, M; Terroir, M | 1 |
| Beer, AJ; Riepe, MW; Vonend, C; Walther, B | 1 |
| Marquez-Medina, D; Martin-Marco, A; Popat, S | 1 |
| Baud, MO; Seeck, M; Vulliemoz, S | 1 |
| Antoch, G; Bergmann, C; Buchbender, C; Forsting, M; Heusch, P; Ruhlmann, M; Ruhlmann, V; Schaarschmidt, BM; Schlamann, M; Wetter, A | 1 |
| Abruzzese, E; Bocchia, M; Bono, R; Bosi, A; Cencini, E; Cox, MC; Di Lollo, S; Di Napoli, A; Fabbri, A; Fratoni, S; Gini, G; Goteri, G; Kovalchuk, S; Lazzi, S; Leoncini, L; Mancuso, S; Rigacci, L | 1 |
| Alam, SR; Carruthers, K; Dweck, MR; Fletcher, AM; Fox, KA; Hoo, TY; Jenkins, WS; Joshi, NV; Langlands, SP; Melville, AJ; Mills, NL; Newby, DE; Rudd, JH; Shah, AS; Sills, A; Toor, I; Uren, NG; van Beek, EJ; Vesey, AT | 1 |
| Attili, A; Chiaravalloti, A; Duggento, A; Guerrisi, MG; Schillaci, O; Strigari, L | 1 |
| Anastasia, A; Biasoli, I; Federico, M; Ferrari, A; Galimberti, S; Luminari, S; Manni, M; Petrini, M; Rusconi, C; Versari, A | 1 |
| Haga, H; Kondo, T; Nakamoto, Y; Otsuka, Y; Takaori-Kondo, A | 1 |
| Cunningham, I; Kohno, B | 1 |
| Chan, HY; Ho, JC; Lee, EY; Tsoi, A; Wong, MP | 1 |
| Abdelhafez, YG; El Refaei, S; Hamada, E; Osama, A; Tawakol, A | 1 |
| Blaise, D; Bouabdallah, R; Broussais, F; Charrier, N; Coso, D; El Cheikh, J; Granata, A; Saillard, C; Schiano, JM | 1 |
| Dauchy, FA; de Clermont-Gallerande, H; Dupon, M; Dutertre, A; Dutronc, H; Fernandez, P; Fournier, C; Lawson-Ayayi, S; Vital, JM; Zanotti-Fregonara, P | 1 |
| Bollineni, VR; Bollineni-Balabay, O; Haldorsen, IS; Salvesen, HB; Ytre-Hauge, S | 1 |
| Huang, G; Li, P; Liu, J; Liu, Q; Song, S; Wang, C; Wang, T | 1 |
| Fujii, S; Fukunaga, T; Matsuki, T; Michimoto, K; Ogawa, T; Sakamoto, H; Tahara, T; Tanino, T; Uchida, N | 1 |
| Bakrin, N; Dubreuil, J; Giammarile, F; Glehen, O; Isaac, S; Passot, G; Rousset, P; Skanjeti, A | 1 |
| Choi, YJ; Han, YM; Hwang, HS; Koh, SH; Park, HC | 1 |
| Adams, HJ; Kwee, TC | 1 |
| Fu, Z; Li, Q; Li, Z; Liu, M; Zhang, J | 1 |
| Han, YH; Jeong, HJ; Lim, ST; Sohn, MH | 1 |
| Ahn, BC; Jeong, SY; Kang, SM; Lee, J; Lee, SJ; Lee, SW; Son, SH | 1 |
| Esbah, AÜ; Esbah, O; Öneç, B; Öneç, K | 1 |
| Ben Taylor, M; Bishton, MJ; Bloor, AJC; Chakraverty, R; Fielding, AK; Fox, CP; Kayani, I; Mackinnon, S; Morris, EC; Peggs, KS; Reyal, Y; Russell, N; Sjursen, AM; Thomson, KJ | 1 |
| Balogova, S; Calzada, M; Cassou-Mounat, T; Devaux, JY; Garderet, L; Huchet, V; Kerrou, K; Mohty, M; Nataf, V; Talbot, JN | 1 |
| An, HJ; Chang, JM; Cheon, GJ; Cho, N; Ha, S; Han, W; Im, SA; Kim, WH; Lee, JS; Lee, SH; Moon, WK; Ryu, HS | 1 |
| Baetz, T; Berge, C; Buckstein, R; Caballero, D; Crump, M; Fine, G; Fingerle-Rowson, G; Gaidano, G; Goy, A; Kostakoglu, L; Martinelli, G; Press, O; Sahin, D; Sehn, L | 1 |
| Burkill, GJ; Dizdarevic, S; Gilbert, DC; Jones, JR; McKinna, F; Teagle, AR | 1 |
| Jeon, MH; Lee, JW; Lee, SM; Shim, JJ | 1 |
| De Carvalho Bittencourt, M; Dolivet, G; Faure, GC; Mastronicola, R; Tu, Q; Wu, X | 1 |
| Czuczman, MS; Graf, DA; Lamonica, D; Munteanu, MC | 1 |
| Chen, M; Diao, X; Huang, B; Li, J; Li, Y; Liu, J | 1 |
| Chiti, A; Costa, G; Lopci, E; Pedicini, V; Poretti, D; Rodari, M; Solbiati, L; Torzilli, G; Viganò, L | 1 |
| Fanti, S; Nanni, C; Schuster, DM | 1 |
| Bleibtreu, A; Bouscarat, F; Mahida, B; Rioux, C | 1 |
| Balzarotti, M; Cabrera, ME; Ceriani, L; Chiappella, A; Cunningham, D; Ferreri, AJ; Giovanella, L; Gospodarowicz, MK; Guarini, A; Johnson, PW; Martelli, M; Ricardi, U; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
| Akhtari, M; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Garg, N; Gunther, JR; Khoury, JD; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL; Suki, T; Yehia, ZA | 1 |
| Agarwal, R; Aggarwal, AN; Gupta, D; Maturu, VN; Mittal, BR; Rayamajhi, SJ | 1 |
| Casasnovas, RO; Rossi, C | 1 |
| Franzen, D; Greutmann, M; Kolios, A; Liebscher, F; Pfammatter, T | 1 |
| Bailly, C; Bodet-Milin, C; Bourgeois, M; Carlier, T; Chérel, M; Guérard, F; Jamet, B; Kraeber-Bodéré, F; Leforestier, R; Moreau, P; Touzeau, C | 1 |
| Ahn, CS; Hwang, S; Jung, DH; Kang, WH; Kim, KH; Lee, SG; Lee, YJ; Moon, DB; Park, GC; Song, GW | 1 |
| Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Misch, D; Schönberger, S; Steffen, IG; Stöver, B; Voelker, T | 1 |
| Blockmans, D; Bobbaers, H; Coudyzer, W; De Ceuninck, L; Heye, S; Loeckx, D; Marchal, G; Stroobants, S; Vanderschueren, S | 1 |
| Alousi, AM; Anderlini, P; Champlin, RE; de Lima, M; Giralt, SA; Hosing, C; Kebriaei, P; Khouri, IF; Korbling, M; Macapinlac, HA; Okoroji, GJ; Popat, U; Qazilbash, MH; Saliba, RM; Samuels, BI | 1 |
| Allen, TW; Davison, JM; Holley, TS; Jurgens, JS; Montilla-Soler, JL; Stack, AL; Stocker, DJ | 1 |
| Chen, YJ; Lai, CR; Liu, RS; Shen, SH; Shieh, HJ; Sung, PL; Wang, PH; Wen, KC; Yen, MS; Yuan, CC | 1 |
| Erturk, SM; Van den Abbeele, AD | 1 |
| Ambrosini, V; Castellucci, P; Fanti, S; Franchi, R; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Godwin, JD; Lewis, DH; Manchanda, V; Martins, RG; Pipavath, SN; Schmidt, RA | 1 |
| Gill, S; Hicks, RJ; Januszewicz, H; Prince, HM; Ritchie, D; Seymour, JF; Wolf, M | 1 |
| Bonardel, G; Coindre, JM; Foehrenbach, H; Gontier, E; Mantzarides, M; Schlaifer, D; Soret, M | 1 |
| Escalón, MP; Han, HS; Hsiao, B; Lossos, IS; Serafini, A | 1 |
| Chen, Y; Huang, G; Liu, J; Sun, X; Tong, J; Xue, H; Zhang, C; Zheng, P | 1 |
| Bolcak, K; Janikova, A; Kral, Z; Mayer, J; Pavlik, T | 1 |
| Bouchiat, C; Carlioz, R; Cellarier, GR; Jego, C; Kerebel, S; Laurent, P; Pons, F; Poyet, R | 1 |
| Higashi, K; Ito, K; Kato, T; Kobayashi, T; Niho, S; Sakuma, T; Sekiguchi, R; Takahashi, T; Tonami, H; Ueda, Y | 1 |
| Castellon, I; Cholewinski, W; Heiba, SI; Raphael, B | 1 |
| Hamlin, PA; Hoppe, BS; Maragulia, JC; Moskowitz, CH; Reiner, AS; Rice, RD; Yahalom, J; Zelenetz, AD; Zhang, Z | 1 |
| Bärthel, E; Freesmeyer, M; Gottschild, D; Habrecht, O; Jandt, K; Katenkamp, K; Kornberg, A; Sappler, A; Settmacher, U; Steenbeck, J | 1 |
| Jheon, S; Kim, DJ; Kim, HR; Lee, WW; Sung, SW | 1 |
| Alinari, L; Ambrosini, V; Baccarani, M; Bacci, F; Broccoli, A; Castellucci, P; Derenzini, E; Fanti, S; Fina, M; Marchi, E; Montini, G; Musuraca, G; Pellegrini, C; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Dunn, J; Fisher, S; MacCabe, C; MacLennan, K; Mehanna, H; Nutting, C; Wong, WL | 1 |
| Abe, T; Mochizuki, Y; Okumura, T; Saito, H; Sato, M; Shioyama, Y; Yamashita, H; Yoshimi, F | 1 |
| Bisi, G; Castellano, G; Deandreis, D; Penna, D; Varetto, T | 1 |
| Henderson, R; Ho, LT; Seto, J; Wassef, H | 1 |
| Assanelli, A; Bregni, M; Ciceri, F; Crocchiolo, R; Fallanca, F; Fazio, F; Ferreri, AJ; Gianolli, L; Giovacchini, G; Pescarollo, A; Ponzoni, M; Verona, C | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Ng, SH; Wang, HM; Yen, TC | 1 |
| El-Maghraby, T; Gambhir, SS; Iagaru, A; McDougall, IR; Mittra, E; Quon, A; Rodriguez, CA | 1 |
| Galanski, M; Joerdens, S; Kiesel, H; Knapp, WH; Rodt, T; von Falck, C; Waldeck, S | 1 |
| Hsieh, TC; Kao, CH; Liang, JA; Lin, YY; Sun, SS; Wang, CH; Wu, YC; Yen, KY | 1 |
| Bögel, L; Burchert, W; Meyer, E; Schmoor, O; Schuppert, F; Tiesmeier, J | 1 |
| Bishai, WR; Davis, SL; Jain, SK; Jedynak, B; Nuermberger, EL; Pomper, MG; Um, PK; Vidal, C | 1 |
| Fujii, H; Fukuda, H; Kanegae, K; Kaneta, T; Kitajima, K; Kubota, K; Murakami, K; Nakajima, K; Nakamoto, Y; Suga, T; Tamaki, N; Tateishi, U | 1 |
| Kim, IJ; Kim, SJ; Kim, YK; Lee, JS; Suh, KT | 1 |
| Hiyama, A; Kawakami, Y; Matsunaga, N; Suga, K; Takeda, K; Tanizawa, Y | 1 |
| Balbi, T; Biasco, G; Castellucci, P; Di Cicilia, R; Fanti, S; Nannini, M; Pantaleo, MA; Zannetti, G | 1 |
| Huang, YT; Kumar, AS; Lee, JC | 1 |
| Galanski, M; Knapp, WH; Laenger, F; von Falck, C | 1 |
| Borbényi, Z; Deák, B; Galuska, L; Illés, A; Keresztes, K; Marton, I; Miltényi, Z; Molnár, Z; Rosta, A; Schneider, T; Simon, Z; Trón, L; Várady, E | 1 |
| Balink, H; de Visscher, JG; Dijkstra, PU; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF | 1 |
| Björo, T; Bogsrud, TV; Hay, ID; Karantanis, D; Kasperbauer, JL; Lowe, VJ; Mullan, BP; Nathan, MA; Reading, CC; Wiseman, GA | 1 |
| Kaji, Y; Kitajima, K; Kubota, K; Murakami, K; Shimoda, M; Suganuma, N; Sugimura, K; Yamasaki, E | 1 |
| Jaaback, K; Proietto, A; Raj, G | 1 |
| Braun, JJ; Imperiale, A; Riehm, S; Veillon, F | 1 |
| Baek, JH; Hong, SJ; Kim, ES; Kim, EY; Kim, TY; Kim, WB; Kim, WG; Lee, JH; Ryu, JS; Shong, YK; Yoon, JH | 1 |
| Diadori, P; Dubois, J; Lambert, R; Turpin, S | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA | 1 |
| Grünwald, F; Happel, C; Kranert, WT; Middendorp, M; Selkinski, I | 1 |
| Chen, PR; Chiu, CH; Hsieh, HJ; Kao, PF; Liu, DW; Liu, SH | 1 |
| Bilici, A; Canpolat, N; Gumus, M; Seker, M; Ustaalioglu, BB | 1 |
| Bashir, H; Daw, NC; Dome, JS; Gelfand, MJ; Moinul Hossain, AK; Nadel, HR; Sharp, SE; Shulkin, BL | 1 |
| Jee, KN; Lee, JH; Namgung, H; Park, DG; Park, SG; Song, IH | 1 |
| Bertolini, F; Cavazza, A; Guicciardi, N; Marchioni, A; Rossi, G; Valli, R | 1 |
| Bal, CS; Halanaik, D; Kumar, R; Malhotra, A; Reddy, RM; Shamim, SA; Shandal, V | 1 |
| Ito, K; Kubota, K; Matsuda, H; Morooka, M; Shiibashi, M; Yokoyama, J | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, EA; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA | 1 |
| Alevizaki, M; Datseris, IE; Piaditis, G; Rondogianni, P; Skoura, E; Tolis, G; Tsagarakis, S; Tzanela, M | 1 |
| Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Nam, BH; Park, NH; Song, YS | 1 |
| Itabashi, M; Kameoka, S; Kondo, C; Kusakabe, K; Kyoto, Y; Momose, M | 1 |
| Ansquer, C; Brunaud, L; Drui, D; Dupas, B; Kraeber-Bodéré, F; Leux, C; Mirallié, E; Renaudin, K; Scigliano, S; Sebag, F; Taïeb, D | 1 |
| Han, SH; Hendriksz, TR; Huiskes, AW; Jansen, I; van Bommel, EF | 1 |
| Dickinson, M; Grigg, A; Hoyt, R; Prince, HM; Ritchie, D; Roberts, AW; Seymour, JF; Szer, J | 1 |
| Auf, G; Blechschmidt, C; Brenner, W; Denecke, T; Geworski, L; Nyuyki, F; Plotkin, M; Stockhammer, F | 1 |
| Aquino, SL; Crowley, D; Feng, Y; Hochberg, EP; Lacasce, AS; Lee, AI; Neuberg, DS; Toomey, C; Van den Abbeele, AD; Zuckerman, DS | 1 |
| Higashi, K; Ishigaki, Y; Nishida, H; Oguchi, M; Ohta, Y; Sakuma, T; Takegami, T; Tonami, H; Ueda, Y; Xu, K; Zhang, L | 1 |
| Franzmann, E; Gomaa, O; Kalkanis, D; Kittaneh, M; Montague, N; Serafini, AN | 1 |
| Anderson, CS; Esiashvili, N; Goodman, M; Halkar, R; Keller, FG; Marcus, RB; Robertson, VL | 1 |
| Jeph, S; Kumar, R; Malhotra, A; Shamim, SA; Shandal, V; Singh, H | 1 |
| Bramanti, S; Castagna, L; Ciceri, F; Corradini, P; Crippa, F; Crocchiolo, R; Dodero, A; Englaro, E; Fallanca, F; Frungillo, N; Miceli, R; Milani, R; Patriarca, F | 1 |
| Gallamini, A; Grimaldi, F; Nicolai, E; Pane, F; Picardi, M; Soricelli, A | 1 |
| Hiyama, J; Kaneko, K; Omagari, J; Ono, K; Yoshida, T | 1 |
| Goldschmidt, N; Klein, M; Or, O; Paltiel, O; Savitsky, B | 1 |
| Ito, K; Kubota, K; Morooka, M; Yokoyama, J | 1 |
| Chen, KY; Chiu, JS; Ho, KW; Hsu, CH; Hung, GU; Kao, CH | 1 |
| Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Park, NH; Song, YS | 1 |
| Bilici, A; Canpolat, N; Gumus, M; Kefeli, U; Ozugur, S; Seker, M; Tekinsoy, B; Ustaalioglu, BB | 1 |
| Alarcon, Pd; Chen, L; Cole, PD; Drachtman, RA; McCarten, KM; Schwartz, CL; Trippett, TM | 1 |
| Baretta, Z; Cervino, AR; Evangelista, L; Ghiotto, C; Gregianin, M; Saladini, G; Sotti, G; Vinante, L | 1 |
| Hirata, Y; Hosoya, Y; Inajima, T; Ishizaka, N; Nagai, R; Shimizu, T; Takahashi, M; Takeda, N; Yamashita, H | 1 |
| Amoura, Z; André, M; Aumaître, O; Charlotte, F; Grimon, G; Guettrot-Imbert, G; Haroche, J; Kelly, A; Ninet, J; Possenti, S | 1 |
| Andreou, J; Filippi, V; Georgiou, E; Laspas, F; Malamitsi, J; Prassopoulos, V; Vlachou, F | 1 |
| Bal, CS; Halanaik, D; Kumar, G; Kumar, R; Malhotra, A; Shamim, SA; Shandal, V | 1 |
| Bruna-Muraille, C; Cuif-Job, A; Guedec-Ghelfi, R; Liehn, JC; Papathanassiou, D; Pochart, JM | 1 |
| Li, HS; Wang, MF; Wang, QS; Wu, HB | 1 |
| Dimitrakopoulou-Strauss, A; Eisenhut, M; Haberkorn, U; Schmieder, K; Seiz, M; Strauss, LG; Tuettenberg, J | 1 |
| Kaji, M; Kanazawa, S; Katayama, N; Katsui, K; Okumura, Y; Sato, S; Suzuki, E; Takemoto, M; Yoshio, K | 1 |
| Aoyagi, T; Kubota-Chikai, K; Kuroda, N; Nonomura, K; Shinohara, N | 1 |
| Bernshaw, DM; Gill, S; Herschtal, A; Hicks, RJ; Narayan, K; Siva, S; Thomas, JM | 1 |
| Ciarallo, A; Derbekyan, V; Hickeson, M; Makis, W | 1 |
| Lee, G; Lee, JH; Park, SG | 1 |
| Antonino, AT; Blagosklonov, O; Bresson-Hadni, S; Brientini, MP; Delabrousse, E; Gillet, M; Grenouillet, F; Ito, A; Knapp, J; Mantion, GA; Minello, A; Richou, C; Sako, Y; Vuitton, DA | 1 |
| Han, SS; Kim, SK; Kim, TS; Lee, JW; Lee, SM; Park, SJ | 1 |
| Alberini, JL; Bellet, D; Brain, E; Champion, L; Edeline, V; Giraudet, AL; Le Stanc, E; Madar, O; Pecking, A; Wartski, M | 1 |
| Baretta, Z; Bozza, F; Cervino, AR; Evangelista, L; Ghiotto, C; Gregianin, M; Saladini, G; Vinante, L | 1 |
| Lindskog, DM; Nikkhou, K; Talusan, P | 1 |
| Hebbar, S; Kadooka, M; Kakushima, N; Kimura, H; Matsubayashi, H; Ono, H; Sawai, H; Takao, T; Takizawa, K; Tanaka, M; Yamaguchi, Y | 1 |
| Abboud, CN; Bartlett, NL; Cashen, AF; Dehdashti, F; Dipersio, JF; Fehniger, TA; Homb, A; Smeltzer, JP; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Westervelt, P; Zhang, Q | 1 |
| Hong, JH; Kim, SE; Lee, JK; Lee, KW; Lee, NW; Song, SH | 1 |
| Ciarallo, A; Makis, W; Michel, RP; Novales-Diaz, JA | 1 |
| Bal, C; Julka, PK; Kumar, R; Malhotra, A; Santra, A; Sharma, P | 1 |
| Flemming, DJ; Fotos, JS; Tulchinsky, M | 1 |
| Ho, L; Kaushik, A; Wassef, H; Zhang, W | 1 |
| Chao, A; Ho, KC; Hong, JH; Huang, KG; Huang, YT; Lai, CH; Lin, G; Qiu, JT; Wang, CC; Yen, TC | 1 |
| Brichon, PY; Chaffanjon, P; Guigard, S; Righini, C | 1 |
| Huang, YY; Lee, MY; Lee, PI; Liu, MC; Tan, TD; You, DL | 1 |
| Abe, K; Hatakenaka, M; Honda, H; Nakamura, K; Nakashima, T; Nonoshita, T; Ohga, S; Ohnishi, K; Shioyama, Y; Yoshitake, T; Yoshiura, T | 1 |
| Erbay, G; Ibis, E; Kucuk, ON; Ozkan, E; Soydal, C | 1 |
| Chung, SK; Kim, SH; Lin, C; Lin, Q; Na, SJ; O, JH; Yoo, IeR | 1 |
| Adang, EM; Bleeker-Rovers, CP; Kullberg, BJ; Oyen, WJ; Vos, FJ | 1 |
| Ahonen, A; Arola, J; Ebeling, T; Heiskanen, I; Kajander, S; Kauhanen, S; Korsoff, P; Lisinen, I; Minn, H; Nuutila, P; Sane, T; Schalin-Jäntti, C; Schildt, J; Seppänen, M; Väisänen, M; Välimäki, MJ; Virtanen, S | 1 |
| Hamatani, H; Hiromura, K; Ikeuchi, H; Kuroiwa, T; Maeshima, A; Matsumoto, T; Nojima, Y; Sakairi, T; Sakurai, N; Umemoto, A | 1 |
| Bartenstein, P; Cumming, P; Graute, V; Hacker, M; Hartenbach, M; Jansen, N; Klanke, K; Scherr, MK; Seitz, M; Thieme, S; Tiling, R; Ubleis, C | 1 |
| Ayuk, F; Derlin, T; Habermann, CR; Herrmann, J; Klutmann, S; Kröger, N; Weber, C; Wisotzki, C; Wolschke, C | 1 |
| Chan, KW; Chan, T; Cheung, C; Hung, KN; Kwong, YL; Lopes, D | 1 |
| Shah, MA; Smyth, EC | 1 |
| Padhy, AK; Tan, ML | 1 |
| Alberini, JL; Bellet, D; Champion, L; Edeline, V; Giraudet, AL; Le Stanc, E; Lerebours, F; Madar, O; Mortazavi-Jehanno, N; Pecking, AP | 1 |
| Ambrosini, V; Castaldi, P; Cremonini, N; de Waure, C; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Santimaria, M; Treglia, G; Versari, A; Villani, MF | 1 |
| Berenger, N; de Roquancourt, A; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Marty, M; Vercellino, L | 1 |
| Borgato, L; Cervino, AR; Dalla Palma, M; Evangelista, L; Fiduccia, P; Gregianin, M; Nicoletto, MO; Saladini, G; Zagonel, V | 1 |
| Kita, M; Kitajima, K; Nakamoto, Y; Senda, M; Sugimura, K; Suzuki, K | 1 |
| Basu, S; Kand, P; Kumar Dhingra, V | 1 |
| Chen, IH; Fan, KH; Hsueh, C; Huang, SF; Kang, CJ; Lee, LY; Liao, CT; Lin, CH; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Coleman, RE; Duan, F; Gareen, IF; Hanna, L; Hillner, BE; Quinn, B; Shields, AF; Siegel, BA | 1 |
| Barry, M; Crowe, M; Dolan, E; Foran, P; Grant, T; Hannon, N; Kavanagh, E; Kelly, PJ; Marnane, M; McDonnell, C; Merwick, A; Moroney, J; Murphy, S; Noone, I; O'Connell, M; O'Donohoe, M; O'Malley, K; O'Rourke, K; Sheehan, OC | 1 |
| Botteri, E; Calabrese, L; Cocorocchio, E; Martinelli, G; Peccatori, F; Piperno, G; Preda, L; Travaini, L; Vanazzi, A | 1 |
| Haraguchi, G; Hirao, K; Inagaki, H; Ishihara, T; Isobe, M; Ohigashi, H; Suzuki, J; Tezuka, D | 1 |
| Adalet, I; Asoglu, O; Balik, E; Has, D; Isik, G; Kapran, Y; Kilic, L; Kuyumcu, S; Ozkan, ZG; Sanli, Y; Turkmen, C | 1 |
| Lee, JW; Lee, MS; Lee, SM; Shin, HC | 1 |
| Bal, C; Jeph, S; Kumar, R; Malhotra, A; Sharma, DN; Sharma, P; Singh, H | 1 |
| Chen, TY; Chiu, JS; Hung, CC; Hung, GU; Kao, CH | 1 |
| Bal, C; Kumar, R; Malhotra, A; Reddy, RM; Sharma, A; Sharma, P; Singh, H; Suman, SK; Thulkar, S | 1 |
| Broski, SM; Hunt, CH; Johnson, GB; Peller, PJ; Subramaniam, RM | 1 |
| Cheng, J; Hu, S; Pan, L; Wang, M; Xu, J; Yang, Z; Ye, D; Zhang, J; Zhang, Y | 1 |
| Antunovic, L; Balestreri, L; Baresic, T; Borsatti, E; Canzonieri, V; Cecchin, D; Cimitan, M; Giorda, G; Pepe, G; Rubello, D; Sorio, R; Steffan, A; Tatta, R | 1 |
| Aras, G; Araz, M; Ozkan, E; Soydal, C | 1 |
| Ahn, BC; Chae, YS; Jeong, SY; Lee, J; Lee, SW; Lee, WK; Song, BI | 1 |
| Boucher, KM; Butterfield, RI; Christian, PE; Enslow, MS; Heilbrun, ME; Hoffman, JM; Jensen, RL; Kadrmas, DJ; Morton, KA; Zollinger, LV | 1 |
| Calabria, F; Schillaci, O | 1 |
| Anthony, MP; Khong, PL; Lee, EY; Tsang, HH | 1 |
| Hauptman, JS; Mathern, GW; Pedram, K; Salamon, N; Sankar, R; Sison, CA; Vinters, HV | 1 |
| Del Ciello, A; Di Franco, D; Treglia, G | 1 |
| de Waal, EG; Slart, RH; Vellenga, E | 1 |
| Kao, PF; Lee, JK; Tseng, CJ; Weng, JH | 1 |
| André, M; Chatelain, B; Krug, BM; Loosen, C; Schollaert, P | 1 |
| Bingaman, W; Jehi, L; Najm, IM; Sarkis, RA | 1 |
| An, GI; An, YS; Cheon, GJ; Choi, TH; Chung, WY; Kim, RM; Lee, J; Nah, KY; Oh, YJ; Soh, EY; Yoon, JK | 1 |
| Bal, C; Kumar, R; Malhotra, A; Sharma, A; Sharma, P; Singh, H; Suman, SK | 1 |
| Brouwers, AH; de Groot, JW; Hofstra, RM; Koopmans, KP; Links, TP; Muller Kobold, AC; Plukker, JT; van der Horst-Schrivers, AN; Verbeek, HH | 1 |
| Katayama, M; Kubota, T; Moritani, S; Yoshino, T | 1 |
| Altieri, ML; Altini, C; Fanelli, M; Merenda, N; Niccoli-Asabella, A; Notaristefano, A; Rubini, G; Stabile-Ianora, AA | 1 |
| Hartridge-Lambert, SK; Lim, RC; Maragulia, JC; Portlock, CS; Schöder, H | 1 |
| Ardeshna, K; Goldstone, AH; Hough, R; Kayani, I; Linch, DC; Morris, EC; Peggs, KS; Thomson, KJ; Virchis, A | 1 |
| Kim, CG; Kim, DW; Kim, WH | 1 |
| Kurabayashi, T; Nakamura, S; Okochi, K; Shibuya, H; Toriihara, A; Watanabe, H | 1 |
| Baik, SH; Hur, H; Kang, J; Kim, H; Kim, NK; Lee, KY; Min, BS; Sohn, SK | 1 |
| Hutchings, M | 1 |
| Aoki, Y; Fujii, H; Kunieda, E; Mizuno, T; Ohashi, T; Oku, Y; Oooka, Y; Ozawa, Y; Sanuki, N; Takeda, A; Yokosuka, N | 1 |
| Hamamoto, Y; Kajihara, M; Kataoka, M; Mochizuki, T; Nakajima, N; Ochi, T; Sakai, S; Sugawara, Y; Takahashi, T; Teramoto, N; Yamashita, M | 1 |
| Blagosklonov, O; Boulahdour, H; Bresson-Hadni, S; Caoduro, C; Grenouillet, F; Porot, C; Richou, C; Vuitton, DA | 1 |
| Balzarini, L; Chiti, A; Lopci, E; Monti, L | 1 |
| Gildehaus, FJ; Götz, C; Hahn, K; Pöpperl, G; Reulen, HJ; Tatsch, K; Yousry, TA | 1 |
| Albertini, P; Alinari, L; Baccarani, M; Chierichetti, F; Ferlin, G; Garraffa, G; Stefoni, V; Tani, M; Tura, S; Zinzani, PL; Zompatori, M | 1 |
| Belhocine, T; De Labrassinne, M; Lahaye, T; Pierard, G; Rigo, P | 1 |
| Belhocine, T; De Barsy, C; Hustinx, R; Willems-Foidart, J | 1 |
| Dupont, P; Garmyn, M; Gysen, M; Hoe, LV; Mortelmans, L; Stas, M; Stroobants, S; Wever, ID | 1 |
| D'Agnolo, A; Durie, BG; Waxman, AD; Williams, CM | 1 |
| Alavi, A; Bagg, A; Baker, G; Downs, L; Elstrom, R; Guan, L; Kim, S; Mehrotra, A; Nakhoda, K; Pitsilos, S; Schuster, SJ; Vergilio, JA; Zhuang, H | 1 |
| Reske, SN | 1 |
| Gottschild, D; Opfermann, T; Voth, M | 1 |
| Dietlein, M; Schicha, H; Schwaiger, M; Weber, W | 1 |
| Pruim, J; Schot, B; Sluiter, W; Vaalburg, W; van Imhoff, G; Vellenga, E | 1 |
| Buck, A; Darge, K; Kern, P; Kratzer, W; Manfras, B; Reske, SN; Reuter, S; Seitz, HM | 1 |
| Bendandi, M; Boán, JF; García-Velloso, MJ; Panizo, C; Pérez-Salazar, M; Richter, J; Rocha, E; Rodríguez-Calvillo, M | 1 |
| Endo, T; Fujimoto, K; Koike, T; Koizumi, K; Kumano, K; Minauchi, K; Nishio, M; Obara, M; Sakai, T; Sato, N | 1 |
| Bain, EE; Bonne, O; Charney, DS; Drevets, WC; Geraci, M; Herscovitch, P; Luckenbaugh, DA; Neumeister, A; Nugent, AC; Schwarz, M; Waldeck, T | 1 |
| Claus, E; Duprez, T; Godfraind, C; Raftopoulos, C; Rutgers, M; Sindic, C | 1 |
| Döbert, N; Grünwald, F; Hamscho, N; Matic, V; Menzel, C; Vasvatekis, S; Wördehoff, N; Zaplatnikov, K | 1 |
| Camatte, S; Jeffry, L; Kerrou, K; Lecuru, F; Lelièvre, L; Metzger, U; Talbot, JN | 1 |
| Devenyi, K; Illes, A; Keresztes, K; Lengyel, Z; Miltenyi, Z; Vadasz, G | 1 |
| Buell, U; Reinartz, P; Schneider, W; Wieres, FJ | 1 |
| Bomanji, JB; Conway, GS; Datta, SN; Kaya, B; Manning, P; Markou, A | 1 |
| Nguyen, BD | 1 |
| Gildehaus, FJ; Goetz, C; Herms, J; Holtmannspötter, M; Koch, W; Kreth, FW; Pöpperl, G; Rachinger, W; Tatsch, K; Tonn, JC | 1 |
| Coleman, M; Goldsmith, SJ; Kostakoglu, L; Leonard, JP | 1 |
| Avril, N; Jacobs, SA; Joyce, J; McCook, B; Torok, F; Vidnovic, N | 1 |
| Eilles, C; Glück, T; Herold, T; Kullmann, F; Müller-Ladner, U; Obermeier, F; Schölmerich, J; Schönberger, J; Tarner, I | 1 |
| Freund, M; Ince, H; Kleine, HD; Körber, T; Nienaber, CA; Petzsch, M; Rehders, T; Schmidt, H; Schümichen, C | 1 |
| Akhurst, T; Chessin, DB; Guillem, JG; Kiran, RP | 1 |
| Gibbs, SD; Gill, SI; Hicks, RJ; Seymour, JF | 1 |
| Blockmans, D; Bobbaers, H; de Ceuninck, L; Knockaert, D; Mortelmans, L; Vanderschueren, S | 2 |
| Pruim, J; Schot, BW; Sluiter, WJ; Vaalburg, W; van Imhoff, GW; Vellenga, E | 1 |
| Altehoefer, C; Bucerius, J; Finke, J; Herkel, C; Joe, AY; Moser, E; Reinhardt, MJ | 1 |
| Schuetze, SM | 1 |
| Delbeke, D; Frangoul, HA; Kuttesch, JF; Martin, W; Rhodes, MM; Shankar, S; Whitlock, JA | 1 |
| Berkhof, J; Buist, MR; Comans, EF; Hoekstra, OS; Hooft, L; Molthoff, CF; van der Veldt, AA; van Diest, PJ | 1 |
| Chang, TC; Hong, JH; Hsueh, S; Huang, HJ; Huang, KG; Lai, CH; Lin, WJ; Ma, SY; Ng, KK; Yen, TC | 1 |
| Ganju, V; Grigg, A | 1 |
| Davidson, T; Goshen, E; Yeshurun, M; Zwas, ST | 1 |
| Altavilla, G; Arrigo, C; Cavallari, V; Naro, C; Navarra, G; Pitini, V | 1 |
| Bosly, A; Graux, C; Krug, B; Nollevaux, MC; Sonet, A; Vander Borght, T | 1 |
| Bar Shalom, R; Ben-Nun, A; Best, AL; Orlovsky, M | 1 |
| Dejaco, C; Duftner, C; Schirmer, M; Wipfler, E | 1 |
| Li, S; Mauch, PM; Ng, AK; Silver, B; Stevenson, MA; Tsai, HK | 1 |
| Kaburaki, J; Kubo, A; Nakahara, T; Shiga, H; Takagi, Y; Uchida, H | 1 |
| Arush, MW; Bar-Shalom, R; Israel, O; Meller, I; Militianu, D; Postovsky, S; Sapir, AE; Zaidman, I | 1 |
| Al-Kattan, K; Al-Sugair, AA; El-Bawab, H; Hajjar, W; Mahdy, M; Rafay, M | 1 |
| Alavi, A; Bing, Z; Chamroonrat, W; Houseni, M; Yang, H; Zhuang, H | 1 |
| Aramendía, JM; Ceamanos, C; García-Velloso, MJ; Garrastachu, MP; Jurado, M; López-García, G; Richter, JA | 1 |
| Nguyen, BD; Ram, PC; Roarke, MC | 1 |
| Bellati, F; Boni, T; Manci, N; Marchetti, C; Morano, G; Panici, PB; Pernice, M | 1 |
| Forman, S; Kirschbaum, MH; Rotter, A; Weiss, L; Zain, J | 1 |
| Hany, TF; Kurrer, M; Schaefer, NG; Strobel, K; Taverna, C; Wastl, C | 1 |
| Cullum, I; Du, Y; Ell, PJ; Illidge, TM | 1 |
| Bairey, O; Herishanu, Y; Metzer, U; Naparstek, E; Perry, C; Polliack, A; Ruchlemer, R; Sapir, EE; Trejo, L | 1 |
| Alavi, A; Hao Tang, P; Liersch, T; Meller, J; Sahlmann, CO | 1 |
| Banavali, S; Basu, S; Nair, N | 1 |
| Amrein, PC; Hales, CA; Kradin, RL; Meyer, GS; Sharma, A | 1 |
| De Renzo, A; Nicolai, E; Pacelli, R; Pane, F; Picardi, M; Rotoli, B; Salvatore, M | 1 |
| Capello, D; Capparella, V; Cianciulli, M; Emili, R; Falchi, L; Liberati, AM; Liberati, F; Pace, R; Palumbo, B; Rauco, A | 1 |
| Inoue, M; Ito, M; Kawakami, S; Kihara, K; Kobayashi, T; Masuda, H; Numao, N | 1 |
| Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Miyakubo, M; Oriuchi, N; Paudyal, B; Paudyal, P; Takano, A; Tsushima, Y | 1 |
| Mortelmans, L; Moulin-Romsee, G | 1 |
| Blockmans, D; Bogaert, J; Breynaert, C; Cornelis, T; Stroobants, S; Vanhoof, J | 1 |
| Bender, H; Biersack, HJ; Pleiss, C; Risse, JH | 1 |
| Fink, GR; Haense, C; Hilker, R; Maarouf, M; Roggendorf, J; Thiel, A; Vent, J | 1 |
| Chua, SC; Green, DJ; Rozalli, FI | 1 |
| Dehdashti, F; Gao, F; Goodgame, B; Govindan, R; Meyers, BF; Patterson, A; Pillot, GA; Shriki, J; Siegel, BA; Yang, Z; Zoole, J | 1 |
| Assanelli, A; Bernardi, M; Bordignon, C; Caligaris-Cappio, F; Canevari, C; Ciceri, F; Clerici, D; Crocchiolo, R; Fazio, F; Ferreri, A; Gianolli, L; Landoni, C; Lunghi, F; Peccatori, J; Servida, P; Stanghellini, ML; Tassara, M | 1 |
| Boyett, JM; Fahey, FH; Kocak, M; Kun, LE; Pollack, IF; Poussaint, TY; Treves, ST; Williams, G | 1 |
| Genoni, M; Schuler, R; Strobel, K | 1 |
| André, N; Colavolpe, C; Coze, C; Fabre, A; Gaudart, J; Gentet, JC; Guedj, E; Jacob, T; Michel, G; Mundler, O; Paris, M | 1 |
| Bishop, J; Frank, A; Gobar, L; Gupta, N; Jaeger, S; Lefkowitz, D; Lynch, H; Mailliard, J; Scott, W; Sunderland, J | 1 |
| Bruner, JM; Janus, TJ; Kim, EE; Tilbury, R; Yung, WK | 1 |
| Einert, A; Laubenberger, JJ; Moser, E; Nitzsche, EU; Simon, GH | 1 |
| Bremner, JD; Bronen, RA; Charney, DS; Dey, H; Duncan, J; Innis, RB; Krystal, JH; Malison, R; Miller, HL; Ng, CK; Price, LH; Rich, D; Salomon, RM; Soufer, R; Staib, LH | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Kuwabara, Y; Masuda, K; Sasaki, M; Yoshida, T | 1 |
| Büll, U; Cremerius, U; Rath, W; Schröder, W; Wolters, S; Zimny, M | 1 |
| Büll, U; Cremerius, U; Fabry, U; Günther, R; Hellwig, D; Neuerburg, J; Osieka, R; Thill, R; Wagenknecht, G | 1 |
| Beese, M; Beyer, W; Bücheler, E; Bumann, D; Clausen, M; de Wit, M; Lübeck, M | 1 |
| Alavi, A; Bénard, F; Fraker, D; Jimenez-Hoyuela, J; Lampreave, JL | 1 |
| Jadvar, H; McDougall, IR; Segall, GM | 1 |
| Maxon, HR | 1 |
| Büll, U; Cremerius, U; Kaiser, HJ; Reinartz, P; Sabri, O; Schreckenberger, M; Zimny, M | 1 |
| Stevens, H; Stokkel, M; Taphoorn, M; Van Rijk, P | 1 |
| Biersack, HJ; Briele, B; Grünwald, F | 1 |
| de Klerk, JH; Koppeschaar, HP; Stokkel, MP; van Rijk, PP; Zelissen, PM | 1 |
| Fridrik, M; Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G | 1 |
| Drucker, WD; Ghossein, RA; Larson, SM; Robbins, HK; Robbins, RJ; Sharaf, RN; Smith, A; Tuttle, RM | 1 |
| Altenvoerde, G; Becker, W; Jauho, A; Lehmann, K; Meller, J | 1 |
| Alavi, A; Denittis, A; Li, P; Machtay, M; Mozley, PD; Smith, R; Yeh, D; Zhuang, H | 1 |
| Hain, S; Maisey, MN; Mikhaeel, NG; O'Doherty, MJ; Timothy, AR | 1 |
| Barnett, G; Chao, ST; Lee, SY; Raja, S; Suh, JH | 1 |
| Boers, M; Devillé, W; Hoekstra, OS; Hooft, L; Lips, P; Teule, GJ; van Tulder, MW | 1 |
| Balzarini, J; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Vandenberghe, P; Verhoef, G | 1 |
| Brinkbäumer, K; Dresel, S; Hahn, K; Pöpperl, G; Schmid, R; Schwenzer, K; Szeimies, U | 1 |
| Swanson, RS | 1 |
| Alexander, HR; Bacharach, SL; Bartlett, DL; Carrasquillo, JA; Choyke, P; Eckelman, WC; Jousse, F; Kranda, K; Libutti, SK; Neumann, RD; Whatley, M | 1 |
| Beuthien-Baumann, B; Bredow, J; Ehninger, G; Franke, WG; Kittner, T; Kropp, J; Naumann, R; Vaic, A | 1 |
| Daldrup-Link, HE; Franzius, C; Heindel, WL; Jürgens, H; Schober, O; Sciuk, J; Wagner-Bohn, A | 1 |
| Buchsbaum, MS; Davis, KL; Hazlett, EA; Haznedar, MM; Powchik, P; Schröder, J; Shihabuddin, L; Singer, MB; Spiegel-Cohen, J; Wei, T | 1 |
| Kao, CH; Lee, CC; Lin, CC; Shen, YY; Shiau, YC; Tsai, MH | 1 |
| Emri, M; Erdélyi, L; Erfán, J; Esik, O; Füle, E; Lengyel, E; Lengyel, Z; Olajos, J; Trón, L | 1 |
38 review(s) available for fluorodeoxyglucose f18 and Recrudescence
| Article | Year |
|---|---|
FDG-PET Imaging in Cervical Cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Recurrence; Uterine Cervical Neoplasms | 2019 |
EDIM-TKTL1/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of Cancer.
Topics: Animals; Apoptosis; Biological Evolution; Biomarkers, Tumor; Biopsy; Blood Chemical Analysis; Early Detection of Cancer; Epitopes; Fluorodeoxyglucose F18; Humans; Immunity, Innate; Lactic Acid; Macrophages; Molecular Targeted Therapy; Monocytes; Neoplasms; Oxythiamine; Positron-Emission Tomography; Recurrence; Transcriptional Activation; Transketolase | 2017 |
Diagnostic value of 18F-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pelvic Neoplasms; Positron-Emission Tomography; Recurrence | 2018 |
18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today?
Topics: Cervix Uteri; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence; Uterine Cervical Neoplasms | 2018 |
The potential of imaging tools as correlates of infection and disease for new TB vaccine development.
Topics: Animals; Biomarkers; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Latent Tuberculosis; Molecular Imaging; Monitoring, Physiologic; Mycobacterium tuberculosis; Positron-Emission Tomography; Recurrence; Sputum; Tomography, X-Ray Computed; Tuberculosis Vaccines; Tuberculosis, Pulmonary; Vaccination | 2018 |
The Prognostic Value of 18F-FDG PET/CT in Monitoring Chemotherapy in Ovarian Cancer Both at Initial Diagnosis and at Recurrent Disease.
Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Treatment Outcome | 2018 |
Potential Role of PET in Assessing Ventricular Arrhythmias.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Chagas Cardiomyopathy; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis | 2019 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
[IgG4-related disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Autoantigens; Autoimmune Diseases; Cytokines; Diagnosis, Differential; Dose-Response Relationship, Drug; Eosinophilia; Fibrosis; Fluorodeoxyglucose F18; Humans; Hypersensitivity; Immunoglobulin G; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Prednisolone; Recurrence; Rituximab; Th2 Cells; Tomography, X-Ray Computed | 2013 |
PET/CT imaging in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Central Nervous System Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; Ephedrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Models, Biological; Models, Chemical; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Tuberculosis biomarkers discovery: developments, needs, and challenges.
Topics: Antigens, Bacterial; Antitubercular Agents; Biomarkers; Disease Progression; DNA, Bacterial; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Gene Expression Regulation, Bacterial; Humans; Interferon-gamma; Interleukin-18; Lipopolysaccharides; Metabolome; MicroRNAs; Multimodal Imaging; Mycobacterium tuberculosis; Polymerase Chain Reaction; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis Vaccines | 2013 |
[Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies].
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Stomach Neoplasms | 2013 |
Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?
Topics: Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Decision Making; Drug Therapy; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Hodgkin Disease; Humans; Immunophenotyping; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Mediastinum; Positron-Emission Tomography; Recurrence; Rituximab; Treatment Outcome | 2015 |
[18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.
Topics: Algorithms; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
Topics: Biopsy; Esophageal Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Quality Control; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[Meta-analysis of PET/CT for diagnosis of residual/recurrent nasopharyngeal carcinoma].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Recurrence | 2016 |
Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Stomach Neoplasms | 2016 |
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Disease Progression; Drug Resistance, Neoplasm; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2016 |
PET Tracers Beyond FDG in Prostate Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers; Recurrence | 2016 |
[New therapy outlooks in Hodgkin lymphoma].
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Brentuximab Vedotin; Cell Cycle Checkpoints; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunoconjugates; Positron Emission Tomography Computed Tomography; Prognosis; Protein Kinase Inhibitors; Radiopharmaceuticals; Recurrence; Reed-Sternberg Cells; Salvage Therapy; Tumor Microenvironment | 2017 |
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.
Topics: Bone Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Treatment Outcome | 2017 |
Role of PET/CT scanning in initial and post-treatment assessment of Hodgkin disease.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed | 2008 |
Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity | 2009 |
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Patient Selection; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Salvage Therapy; Treatment Outcome; Young Adult | 2010 |
Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
Topics: Drug Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Stomach Neoplasms | 2011 |
PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
Topics: Antineoplastic Agents; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Membrane Proteins; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach.
Topics: Carcinoma, Ovarian Epithelial; Decision Making; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed | 2012 |
How does PET/CT help in selecting therapy for patients with Hodgkin lymphoma?
Topics: Decision Support Systems, Clinical; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Medical Oncology; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Risk; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
PET and restaging of malignant lymphoma including residual masses and relapse.
Topics: Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed | 2003 |
[The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].
Topics: Cholangiopancreatography, Endoscopic Retrograde; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
The role of FDG-PET imaging in the management of lymphoma.
Topics: Bone Marrow; Clinical Trials as Topic; Disease Management; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Imaging, Three-Dimensional; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer.
Topics: Carcinoembryonic Antigen; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2005 |
Utility of positron emission tomography in sarcomas.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Sarcoma | 2006 |
Solitary gastric recurrence from ovarian carcinoma: a case report and literature review.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Ovarian Neoplasms; Recurrence; Stomach Neoplasms; Tomography, Emission-Computed | 2006 |
Nonprosthesis orthopedic applications of (18)F fluoro-2-deoxy-D-glucose PET in the detection of osteomyelitis.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Osteomyelitis; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2007 |
Detection of residual and recurrent thyroid cancer by radionuclide imaging.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm, Residual; Radiopharmaceuticals; Recombinant Proteins; Recurrence; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed, Single-Photon | 1999 |
Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Radiopharmaceuticals; Recurrence; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
45 trial(s) available for fluorodeoxyglucose f18 and Recrudescence
| Article | Year |
|---|---|
Identifying the location of locoregional recurrences after definitive radiotherapy for head and neck cancer using metabolic parameters of baseline and mid-treatment 18F-FDG-PET scans.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Squamous Cell Carcinoma of Head and Neck | 2023 |
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Ewing sarcoma during follow-up.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiography; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Young Adult | 2017 |
Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence.
Topics: Anus Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Recurrence; Treatment Outcome | 2018 |
Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Propensity Score; Recurrence | 2019 |
Relationship between the immunohistochemistry of the primary tumour and 18F-FDG-PET/CT at recurrence in patients with well-differentiated thyroid carcinoma.
Topics: Cluster Analysis; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Polyethylene Glycols; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Recombinant Proteins; Recurrence; Rituximab; Tomography, X-Ray Computed; Treatment Failure; Vincristine; Young Adult | 2013 |
Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Recurrence; Tomography, X-Ray Computed | 2014 |
Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?
Topics: Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Probability; Recurrence; Tomography, X-Ray Computed | 2014 |
Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects.
Topics: Adult; Anxiety; Brain; Convulsive Therapy; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Magnetic Field Therapy; Male; Middle Aged; Positron-Emission Tomography; Quality of Life; Radiopharmaceuticals; Recurrence; Treatment Outcome | 2015 |
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Germany; Hodgkin Disease; Humans; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Recurrence; Vincristine | 2015 |
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm, Residual; Oncogene Proteins, Fusion; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Real-Time Polymerase Chain Reaction; Recurrence | 2016 |
Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Whole Body Imaging; Young Adult | 2016 |
FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Pseudomyxoma Peritonei; Recurrence | 2016 |
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome | 2017 |
18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Rituximab; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2017 |
Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence | 2009 |
Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Mouth; Mouth Neoplasms; Multivariate Analysis; Neck; Patient Selection; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Risk Factors; Salvage Therapy; Survival Analysis; Time Factors | 2009 |
18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Recurrence; Time Factors | 2009 |
18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.
Topics: Aged; Carbon Radioisotopes; Choline; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Recurrence; Tomography, X-Ray Computed; Young Adult | 2010 |
(18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
Topics: Acute-Phase Proteins; Aged; Antineoplastic Agents, Hormonal; Disease Progression; Drug Monitoring; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Regression Analysis; Retroperitoneal Fibrosis; Tamoxifen; Tomography, X-Ray Computed | 2010 |
Detection of recurrence in glioma: a comparative prospective study between Tc-99m GHA SPECT and F-18 FDG PET/CT.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Prospective Studies; Recurrence; Sugar Acids; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2011 |
Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia.
Topics: Bacteremia; Cost-Benefit Analysis; Delivery of Health Care; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Risk; Tomography, X-Ray Computed | 2011 |
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Kinetics; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hormones; Humans; Middle Aged; Mucin-1; Multimodal Imaging; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Triple-negative breast cancer: early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapse.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Patient Selection; Positron-Emission Tomography; Recurrence; Risk; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread.
Topics: Adult; Aged; Chemoradiotherapy; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm, Residual; Positron-Emission Tomography; Radiotherapy, Adjuvant; Recurrence; Risk; Survival Analysis | 2012 |
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.
Topics: Adult; Aged; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Recurrence; Young Adult | 2012 |
Is FDG PET a better imaging tool than somatostatin receptor scintigraphy in patients with relapsing multiple myeloma?
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiography; Radionuclide Imaging; Receptors, Somatostatin; Recurrence | 2012 |
Structured treatment interruption in patients with alveolar echinococcosis.
Topics: Adult; Aged; Aged, 80 and over; Anthelmintics; Benzimidazoles; Echinococcosis, Pulmonary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pulmonary Alveoli; Recurrence; Tomography, Emission-Computed | 2004 |
Positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual Hodgkin's disease mediastinal masses.
Topics: False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Survival Rate; Treatment Outcome | 2004 |
Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.
Topics: Adult; Amino Acids, Essential; Brain; Brain Mapping; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fluorodeoxyglucose F18; Genetic Markers; Glucose; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Recurrence; Serotonin; Tomography, Emission-Computed; Treatment Outcome; Tryptophan | 2004 |
Full-dose 90Y ibritumomab tiuxetan therapy is safe in patients with prior myeloablative chemotherapy.
Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal; Antigens, CD20; Blood Platelets; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platelet Count; Pleural Effusion; Positron-Emission Tomography; Radioimmunotherapy; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI).
Topics: Adult; Coronary Angiography; Female; Fluorodeoxyglucose F18; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Myocardial Infarction; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Stem Cell Transplantation; Ventricular Remodeling | 2005 |
Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methylprednisolone; Polymyalgia Rheumatica; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Risk; Shoulder Joint; Treatment Outcome | 2006 |
The role of serial pre-transplantation positron emission tomography in predicting progressive disease in relapsed lymphoma.
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence | 2006 |
Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2007 |
Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse.
Topics: Antidepressive Agents; Brain; Deoxyglucose; Depressive Disorder; Double-Blind Method; Fluorodeoxyglucose F18; Glucose; Humans; Limbic System; Placebos; Prefrontal Cortex; Psychiatric Status Rating Scales; Recurrence; Serotonin; Thalamus; Tomography, Emission-Computed; Tryptophan | 1997 |
An evaluation of FDG-PET in the detection and differentiation of thyroid tumours.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Recurrence; Reference Values; Thyroid Hormones; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography.
Topics: Algorithms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging.
Topics: Adolescent; Adult; Biopsy; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Bone Tissue; Recurrence; Tomography, Emission-Computed | 2002 |
399 other study(ies) available for fluorodeoxyglucose f18 and Recrudescence
| Article | Year |
|---|---|
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Inflammation; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2022 |
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Takayasu Arteritis | 2022 |
Evaluation of response to stereotactic body radiation therapy for nonsmall cell lung cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiosurgery; Recurrence; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Treatment Outcome | 2022 |
Solitary Central Nervous System Relapse of Posttransplant Lymphoproliferative Disorder on 18 F-FDG PET/CT.
Topics: Adult; Central Nervous System; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography; Recurrence | 2022 |
[Myeloid sarcomas of the shoulder and testis relapsing 9 years after allogenic stem cell transplantation for acute myeloid leukemia].
Topics: Fluorodeoxyglucose F18; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Male; Positron Emission Tomography Computed Tomography; Recurrence; Sarcoma, Myeloid; Shoulder; Stem Cell Transplantation; Testis; Transplantation, Homologous | 2022 |
Persistent FDG uptake in large vessels and risk of relapse in giant cell arteritis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2022 |
Multifocal Extramedullary Relapse With Neuroleukemiosis in a Case of Early T-Cell Precursor ALL: 18F-FDG PET/CT Findings.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precursor Cells, T-Lymphoid; Recurrence | 2022 |
The Role of FDG Positron Emission Tomography/Contrast--Enhanced Computed Tomography in Preoperative Staging and Postoperative Follow-up in Rectal Cancer Surgery.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rectal Neoplasms; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Outcomes of solitary postoperative recurrence of esophageal squamous cell carcinoma diagnosed with FDG-PET/CT and treated with definitive radiation therapy.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Recurrence; Retrospective Studies | 2023 |
Absence of infective endocarditis relapse when end-of-treatment fluorodeoxyglucose positron emission tomography/computed tomography is negative.
Topics: Aged; Chronic Disease; Endocarditis; Endocarditis, Bacterial; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence | 2023 |
Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Mitogen-Activated Protein Kinase Kinases; Neoplasms; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Recurrence | 2023 |
A comparison of loco-regional relapse pattern in HPV positive vs negative oropharyngeal cancers following radiotherapy; relation to pretreatment FDG-PET and radiotherapy target volumes.
Topics: Chronic Disease; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Squamous Cell Carcinoma of Head and Neck | 2023 |
PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrosis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Takayasu Arteritis; Young Adult | 2019 |
18F-FDG Positron-Emission Tomography/Computed Tomography Findings of Radiographic Lesions Suggesting Old Healed Pulmonary Tuberculosis and High-risk Signs of Predicting Recurrence: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies; Risk; Tuberculosis, Pulmonary | 2019 |
Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.
Topics: Adalimumab; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Cardiomyopathies; Deprescriptions; Drug Therapy, Combination; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sarcoidosis; Treatment Outcome | 2019 |
Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Gliosarcoma; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Recurrence; Whole Body Imaging | 2019 |
Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence.
Topics: Adenocarcinoma of Lung; Aged; Biological Transport; Carboxylic Acids; Cyclobutanes; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence | 2020 |
[Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Vascular Neoplasms; Vincristine | 2019 |
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis.
Topics: Aged; Aortitis; Cost of Illness; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2020 |
Isolated Immunoglobulin G4-Related Disease of Nasal Septum and Maxilla: Diagnosis and Follow-up With 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoglobulin G4-Related Disease; Maxilla; Middle Aged; Nasal Septum; Positron Emission Tomography Computed Tomography; Recurrence | 2020 |
Establishment and validation of a nomogram with intratumoral heterogeneity derived from
Topics: Adolescent; Adult; Aged; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Nasopharyngeal Carcinoma; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Recurrence; Reproducibility of Results; Young Adult | 2020 |
Cranial and large vessel activity on positron emission tomography scan at diagnosis and 6 months in giant cell arteritis.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; New South Wales; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Time Factors; Treatment Outcome | 2020 |
A retrospective cohort study to assess PET-CT findings and clinical outcomes in Takayasu arteritis: does 18F-fluorodeoxyglucose uptake in arteries predict relapses?
Topics: Adult; Antirheumatic Agents; Biological Products; Cohort Studies; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Longitudinal Studies; Magnetic Resonance Angiography; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; Retrospective Studies; Takayasu Arteritis; Ultrasonography, Doppler, Color | 2020 |
Prognostic value of pretreatment tumor-to-blood standardized uptake ratio (SUR) in rectal cancer.
Topics: Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Rectal Neoplasms; Recurrence; Reference Standards | 2020 |
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Choline; Contrast Media; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2020 |
[18F]-FDG PET/CT for suspected lymphoma relapse in a patient with concomitant pneumococcal pneumonia during COVID-19 outbreak: unexpected SARS-Cov-2 co-infection despite double RT-PCR negativity.
Topics: Betacoronavirus; Coinfection; Coronavirus Infections; COVID-19; Fluorodeoxyglucose F18; Humans; Lymphoma; Nuclear Medicine; Pandemics; Pneumonia, Pneumococcal; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2 | 2020 |
18F-FDG PET/CT Imaging of Vasculitis Complicated With Relapsing Polychondritis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Polychondritis, Relapsing; Positron Emission Tomography Computed Tomography; Recurrence; Vasculitis | 2020 |
18F-Fluorodeoxyglucose PET/CT-Guided Palliative Radiotherapy Provides Durable Responses to Over a Dozen Sites of Disease in Relapsed Myeloid Sarcoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Palliative Care; Positron Emission Tomography Computed Tomography; Radiotherapy, Image-Guided; Recurrence; Sarcoma, Myeloid; Treatment Outcome | 2020 |
Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients.
Topics: Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lysine; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Urea | 2020 |
Topics: Adult; Antigens, CD19; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen; Recurrence; Treatment Failure | 2021 |
Case Report of 18F-FDG PET/CT Features of Polyacrylamide Hydrogel Mammoplasty.
Topics: Acrylic Resins; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma; Mammaplasty; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence | 2021 |
Bilateral Silicone Granulomas Mimicking Breast Cancer Recurrence on 18F-FDG PET/CT.
Topics: Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Silicones | 2021 |
FDG PET/CT in Recurrent Glioblastoma Multiforme With Leptomeningeal and Diffuse Spinal Cord Metastasis.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Meningeal Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Spinal Cord Neoplasms; Temozolomide | 2021 |
Intense Hypermetabolic Tumefactive Demyelination on 18F-FDG PET and MRI Related to Multiple Sclerosis Relapse After Fingolimod Suspension.
Topics: Biopsy; Female; Fingolimod Hydrochloride; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Multiple Sclerosis; Myelin Sheath; Positron-Emission Tomography; Recurrence; Withholding Treatment | 2021 |
Prognostic value of
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prognosis; Progression-Free Survival; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sex Factors; Vincristine; Young Adult | 2021 |
Mediastinal Recurrence of Uterine Cervix Cancer on 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Mediastinal Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Uterine Cervical Neoplasms | 2021 |
Topics: Aorta; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Blood Vessels; Cardiac Surgical Procedures; Fluorodeoxyglucose F18; Fracture Fixation, Internal; Humans; Mediastinitis; Omentum; Positron Emission Tomography Computed Tomography; Postoperative Hemorrhage; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Sternum; Therapeutic Irrigation; Vascular Grafting; Wound Healing | 2021 |
Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET.
Topics: Adult; Aged; Cardiomyopathies; Fatty Acids; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Iodobenzenes; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2021 |
Incremental Role of 18F-FDG-Labeled Autologous Leukocyte PET/CT in Suspected Postoperative Recurrence of Skull Base Osteomyelitis.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Leukocytes; Male; Osteomyelitis; Positron Emission Tomography Computed Tomography; Postoperative Period; Recurrence; Skull Base | 2021 |
A Growing Inflammatory Mass of Gastrosplenic Ligament Mimicking Recurrent Colon Cancer on FDG PET/CT.
Topics: Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Inflammation; Ligaments; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence | 2021 |
Case Report: Incidental Finding of COVID-19 Infection after Positron Emission Tomography/CT Imaging in a Patient with a Diagnosis of Histoplasmosis and Recurring Fever.
Topics: Adult; COVID-19; Female; Fever; Fluorodeoxyglucose F18; Histoplasmosis; Humans; Positron Emission Tomography Computed Tomography; Recurrence; SARS-CoV-2 | 2021 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in atrial fibrillation: a pilot prospective study.
Topics: Atrial Fibrillation; Catheter Ablation; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prospective Studies; Recurrence; Treatment Outcome | 2021 |
Multicentric Reticulohistiocytosis Mimicking Malignancy on 18F-FDG PET/CT.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytosis; Humans; Positron Emission Tomography Computed Tomography; Recurrence; Urologic Neoplasms; Urothelium | 2017 |
18F-Fluorocholine, 18F-FDG, and 18F-Fluoroethyl Tyrosine PET/CT in Parathyroid Cancer.
Topics: Aged; Choline; Female; Fluorodeoxyglucose F18; Humans; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Thyroidectomy; Tyrosine | 2017 |
FDG PET/CT Findings of Nodular Sclerosis-Subtype Classic Hodgkin Lymphoma Presented as Mediastinal Nodal Lesions at Onset But as Predominant Osseous Disease at Relapse.
Topics: Bone Diseases; Chronic Disease; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Recurrence; Sclerosis; Young Adult | 2017 |
Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2016 |
Stensen Duct Relapse of Diffuse Large B-Cell Lymphoma: An Unusual Pattern Detected With 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Parotid Gland; Positron Emission Tomography Computed Tomography; Recurrence | 2017 |
Multiorgan Involvement of Chemotherapy-Induced Sarcoidosis Mimicking Progression of Lymphoma on FDG PET/CT.
Topics: Biopsy; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Recurrence; Sarcoidosis | 2017 |
Debate on the value of end-of-treatment FDG-PET response evaluation in follicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence; Research Design; Survival Analysis; Treatment Outcome | 2017 |
18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography can reliably rule-out infection and cancer in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis suspected of disease relapse.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infections; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging | 2017 |
A pilot study for texture analysis of
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Analysis | 2017 |
Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT.
Topics: Bone Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Recurrence; Scapula | 2017 |
Benefits of respiratory-gated 18F-FDG PET acquisition in lung disease.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Respiratory-Gated Imaging Techniques | 2018 |
Prognostic value of FDG-PET and DWI in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies | 2018 |
End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
Topics: Adult; Aged; Aged, 80 and over; B-Lymphocytes; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Germany; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasm Staging; Organ Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Recurrence; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2018 |
Incidental Detection of Metastatic Malignant Melanoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT Imaging: Correlative Imaging With FDG PET/CT and Review of the Literature.
Topics: Aged, 80 and over; Biopsy, Fine-Needle; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Incidental Findings; Male; Melanoma; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence | 2018 |
Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Contrast Media; Female; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Kinetics; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult | 2018 |
[A Case of Local Recurrence with Negative FDG/PET Findings after a Total Proctocolectomy for Ulcerative Colitis Associated with Colon Cancer with Retroperitoneal Penetration].
Topics: Colectomy; Colitis, Ulcerative; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Wounds, Penetrating | 2017 |
Total FDG lesion number on PET/CT predicts survival of esophageal carcinoma patients with recurrence following curative surgery.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Analysis | 2020 |
Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Japan; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Response Evaluation Criteria in Solid Tumors | 2018 |
Increased FDG-PET/CT pericardial uptake identifies acute pericarditis patients at high risk for relapse.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pericardial Effusion; Pericarditis; Pilot Projects; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Risk Factors; Young Adult | 2018 |
Preoperative omental metastasis-related maximum standardized fluorine-18-fluorodeoxyglucose uptake value can predict chemosensitivity and recurrence in advanced high-grade serous ovarian cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies | 2018 |
18F-FDG PET/CT in an Atypical Case of Relapsed IgG4-Related Disease Presenting as Inflammatory Pseudotumor in Gall Bladder Fossa With Extensive Disease Involvement.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder Diseases; Humans; Immunoglobulin G; Inflammation; Male; Positron Emission Tomography Computed Tomography; Recurrence | 2018 |
Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CD5 Antigens; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Nasal Cavity; Nose Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Treatment Outcome; Vascular Neoplasms | 2018 |
Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer.
Topics: Adult; Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies | 2019 |
Prognostic significance of supradiaphragmatic lymph node metastasis detected by
Topics: Aged; Carcinoma, Ovarian Epithelial; Diaphragm; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies | 2018 |
Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Recurrence; Retrospective Studies; Survival Analysis; Time Factors; Transplantation, Homologous; Young Adult | 2019 |
Diffuse Large B-Cell Lymphoma Recurring as Neurolymphomatosis on FDG PET/CT.
Topics: Aged, 80 and over; Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Recurrence | 2019 |
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [
Topics: Adult; Amino Acids; Child; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Isotope Labeling; Nuclear Medicine; Positron-Emission Tomography; Practice Guidelines as Topic; Quality Control; Recurrence; Reference Standards; Research Design; Societies, Medical | 2019 |
External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Bias; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Diagnostic Accuracy of 18F-FDG PET/CT in Patients With Biochemical Evidence of Recurrent, Residual, or Metastatic Medullary Thyroid Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Young Adult | 2019 |
Split-Dose
Topics: Ablation Techniques; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microwaves; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Dosage; Recurrence; Surgery, Computer-Assisted | 2019 |
Acral Involvement of Lymphoblastic Lymphoma Revealed on FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Foot; Hand; Humans; Male; Positron Emission Tomography Computed Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2019 |
Increased
Topics: Adolescent; Biological Transport; Child; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Palatine Tonsil; Positron Emission Tomography Computed Tomography; Recurrence | 2019 |
Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; France; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retroperitoneal Fibrosis; Retrospective Studies; Risk Assessment | 2019 |
Topics: Aged; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence | 2019 |
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Progression-Free Survival; Radiopharmaceuticals; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Time Factors; Vincristine; Watchful Waiting; Young Adult | 2019 |
Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies.
Topics: Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immune System; Immunotherapy; Nivolumab; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Recurrence; Retrospective Studies; Treatment Outcome | 2019 |
Comparison of subjective evaluation versus objective algorithm in the interpretation of follow-up FDG-PET/CT scans after radiochemotherapy in head and neck cancer patients.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies | 2019 |
Connecting the dots: a story of unknown fever, acute coronary syndrome and pan-aortitis-an occult relapse of a large vessel vasculitis.
Topics: Acute Coronary Syndrome; Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Recurrence; Whole Body Imaging | 2019 |
Combining fluorine-18 fluorodeoxyglucose positron emission tomography and pathological risk factors to predict postoperative recurrence in stage I lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors | 2019 |
Vascular Positron Emission Tomography and Restenosis in Symptomatic Peripheral Arterial Disease: A Prospective Clinical Study.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peripheral Arterial Disease; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors; Sodium Fluoride; Time Factors; Treatment Outcome | 2020 |
Diagnostic value of surveillance
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Treatment Outcome | 2019 |
Fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis.
Topics: Adolescent; Adult; Cough; Ear Auricle; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Cartilages; Male; Middle Aged; Nasal Cartilages; Polychondritis, Relapsing; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Reference Values; Respiratory Sounds; Young Adult | 2020 |
A Case of Sarcoidosis After Lymphoma.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Sarcoidosis | 2019 |
Primary rhabdomyosarcoma of pulmonary artery: 18F-FDG PET/CT for detecting recurrence in a rare tumor.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Artery; Recurrence; Rhabdomyosarcoma; Tomography, X-Ray Computed; Vascular Neoplasms | 2013 |
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Vincristine | 2013 |
Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Differentiation; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Observer Variation; Radionuclide Imaging; Recurrence; Reproducibility of Results; Retrospective Studies; Young Adult | 2013 |
Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroxine; Time Factors | 2013 |
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy as salvage treatment for a late wound recurrence of endometrial cancer.
Topics: Aged; Combined Modality Therapy; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Infusions, Parenteral; Laparotomy; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Salvage Therapy; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Heterogeneous 18F-FDG uptake in recurrent respiratory papillomatosis.
Topics: Adult; Biological Transport; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Papillomavirus Infections; Positron-Emission Tomography; Recurrence; Respiratory Tract Infections; Tomography, X-Ray Computed | 2013 |
FDG PET/CT images demonstrating Fournier gangrene with bilateral pelvic muscle extension in a patient with recurrent rectosigmoid cancer.
Topics: Aged; Fluorodeoxyglucose F18; Fournier Gangrene; Humans; Male; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2014 |
Recurrent dermatofibrosarcoma protuberans with pulmonary metastases presenting twelve years after initial diagnosis: 18F-FDG PET/CT imaging findings.
Topics: Dermatofibrosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2014 |
Prognostic significance of pretreatment ¹⁸F-FDG PET/CT in patients with relapsed/refractory B-cell non-Hodgkin's lymphoma treated by radioimmunotherapy using ¹³¹I-rituximab.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Recurrence; Rituximab; Tomography, X-Ray Computed | 2013 |
Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Young Adult | 2014 |
Clinical utility of 18F-FDG PET/CT concurrent with 131I therapy in intermediate-to-high-risk patients with differentiated thyroid cancer: dual-center experience with 286 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Risk; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2013 |
New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Risk Assessment; Risk Factors; Tomography, X-Ray Computed | 2013 |
Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis.
Topics: Adult; Aged; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Infliximab; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Receptors, Interleukin-2; Recurrence; Retrospective Studies; Sarcoidosis; Time Factors | 2014 |
Recurrence of a functional adrenocortical oncocytoma of borderline malignant potential showing high FDG uptake on 18F-FDG PET/CT.
Topics: Adenoma, Oxyphilic; Adrenal Cortex Neoplasms; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2014 |
Clinical impact of 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-positron emission tomography (PET) on treatment choice in recurrent cancer of the cervix uteri.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Choice Behavior; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Recurrence; Uterine Cervical Neoplasms | 2013 |
Value of F-18 FDG PET/CT in detection and prognostication of isolated extra-axillary lymph node recurrences in postoperative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer.
Topics: Adult; Aged; Dissection; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2014 |
The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
Topics: Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2014 |
Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Patient Outcome Assessment; Pharynx; Positron-Emission Tomography; Recurrence; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Child; Disease-Free Survival; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous | 2014 |
Is there an impact of 18F-FDG PET/CT on the surveillance and clinical management of recurrent ovarian cancer? Research based on a large sample in a single PET/CT center.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Decision Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Unusual site of metastasis detected with FDG PET/CT in a case of recurrent rectosigmoid cancer.
Topics: Aged; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2014 |
Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism.
Topics: Aged; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; NF-kappa B; Positron-Emission Tomography; Prognosis; Recurrence; Tissue Array Analysis; Up-Regulation | 2014 |
Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Recurrence; ROC Curve; Thymine; Treatment Outcome | 2014 |
High-dose chemotherapy followed by autologous peripheral blood stem cell transplantation for recurrent primary mediastinal malignant germ cell tumor: a case report.
Topics: Adolescent; Antineoplastic Agents; Biopsy; Brachiocephalic Veins; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Recurrence; Subclavian Vein; Tomography, X-Ray Computed; Treatment Outcome; Vena Cava, Superior | 2014 |
Optimizing the outcome of vascular intervention for Takayasu arteritis.
Topics: Adult; Angioplasty; Aortic Aneurysm, Thoracic; Carotid Artery Diseases; Combined Modality Therapy; Constriction, Pathologic; Coronary Disease; Dilatation, Pathologic; Endovascular Procedures; Female; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Magnetic Resonance Angiography; Male; Middle Aged; Preoperative Care; Radiopharmaceuticals; Recurrence; Renal Artery Obstruction; Reoperation; Retrospective Studies; Stents; Takayasu Arteritis; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler; Vascular Patency | 2014 |
Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis.
Topics: Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Recurrence; Time Factors | 2014 |
Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Atrioventricular Block; Biopsy; Cardiomyopathies; Defibrillators, Implantable; Disease-Free Survival; Electric Countershock; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Male; Middle Aged; Ontario; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors; Sarcoidosis; Tachycardia, Ventricular; Time Factors; Tomography, X-Ray Computed; Young Adult | 2014 |
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Young Adult | 2014 |
A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hematologic Neoplasms; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasms, Plasma Cell; Nuclear Physics; Positron-Emission Tomography; Prospective Studies; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Recurrence; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2014 |
Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2016 |
Intraluminal Superior Vena Cava Metastasis in a Patient With Poorly Differentiated Thyroid Carcinoma.
Topics: Adenocarcinoma; Aged; Cough; Deglutition Disorders; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Respiratory Sounds; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Vascular Neoplasms; Vena Cava, Superior | 2015 |
Preoperative PET/CT standardized FDG uptake values of pelvic lymph nodes as a significant prognostic factor in patients with endometrial cancer.
Topics: Adult; Aged; Biological Transport; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.
Topics: Animals; Case-Control Studies; Cohort Studies; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Ligation; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multimodal Imaging; Neutropenia; Neutrophils; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thrombosis; Time Factors; Tomography, X-Ray Computed; Venous Thrombosis | 2014 |
Imaging the evolution of reactivation pulmonary tuberculosis in mice using 18F-FDG PET.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Lung; Mice; Mice, Inbred C3H; Mycobacterium tuberculosis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2014 |
The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2015 |
(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radioactive Tracers; Radiopharmaceuticals; Rats; Recurrence; Tyrosine | 2015 |
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Stem Cell Transplantation; Tomography, X-Ray Computed | 2014 |
Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Squamous Cell Carcinoma of Head and Neck; Thionucleosides; Thymidine; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Carotid inflammation on ¹⁸F-fluorodeoxyglucose positron emission tomography associates with recurrent ischemic lesions.
Topics: Aged; Carotid Artery Diseases; Carotid Stenosis; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Ischemia; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors | 2014 |
Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Retrospective Studies | 2015 |
18F-FDG-PET/CT in staging, recurrence detection and response evaluation of primary splenic lymphoma with eight years follow up.
Topics: Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Spleen; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
Topics: Adult; Aged; Biological Transport; Blood Glucose; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm, Residual; Positron-Emission Tomography; Recurrence | 2015 |
[A case report of surgical treatment for hepatocellular carcinoma with a Hugely swollen lymph node that showed high FDG uptake].
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2014 |
Safety and cost analysis of an (18)FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hospital Costs; Humans; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2015 |
The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Graft Survival; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Positron-Emission Tomography; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Siblings; Survival Analysis; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors | 2015 |
Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Time Factors; Transplantation, Autologous | 2015 |
[Imaging diagnosis of biliary tract cancer on PET].
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence | 2015 |
Plaque Inflammation Imaging in Severe Carotid Stenosis and Recurrent Cerebral Ischemia.
Topics: Brain Ischemia; Carotid Stenosis; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Recurrence | 2015 |
[Mixed histiocytosis, a rare cause of stroke].
Topics: Aged, 80 and over; Antigens, CD; Antigens, CD1; Antigens, Differentiation, Myelomonocytic; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarction; Colitis; Diarrhea; Endarterectomy, Carotid; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Histiocytes; Histiocytosis; Humans; Magnetic Resonance Imaging; Platelet Aggregation Inhibitors; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Ultrasonography; Vertebrobasilar Insufficiency; Weight Loss | 2015 |
A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets.
Topics: Animals; Antitubercular Agents; Callithrix; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluorodeoxyglucose F18; Granuloma; Male; Mycobacterium tuberculosis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Tuberculosis | 2015 |
Chronological assessment of airway lesions in relapsing polychondritis by positron emission tomography.
Topics: Adult; Bronchoscopy; Chest Pain; Costal Cartilage; Cyclosporine; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Methotrexate; Multimodal Imaging; Polychondritis, Relapsing; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Trachea | 2015 |
¹⁸F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
Topics: Aged; Biopsy; Colorectal Neoplasms; Electronic Health Records; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Recurrence; Registries; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Use of temozolomide instead of cyclophosphamide in diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Dacarbazine; Drug Hypersensitivity; Drug Substitution; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Recurrence; Temozolomide; Treatment Outcome; Young Adult | 2016 |
Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Attention; Cognition Disorders; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Essential Tremor; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Lithium Compounds; Male; Memory Disorders; Memory, Episodic; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Primidone; Radiopharmaceuticals; Recurrence; Venlafaxine Hydrochloride | 2015 |
Watch the weathercock: changes in re-staging 18F-FDG PET/CT scan predict the probability of relapse in locally advanced non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Recurrent secondary generalization in frontal lobe epilepsy: Predictors and a potential link to surgical outcome?
Topics: Adolescent; Adult; Cohort Studies; Electroencephalography; Epilepsy, Frontal Lobe; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Seizures; Treatment Outcome; Young Adult | 2015 |
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Vinblastine; Young Adult | 2017 |
Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction.
Topics: Aged; Aortitis; Atherosclerosis; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Myocardial Infarction; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Registries; Risk Factors; Scotland; Time Factors; Tomography, X-Ray Computed; Troponin | 2015 |
Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed; Young Adult | 2016 |
18F-FDG PET/CT and MRI findings in a case of granulocytic sarcoma of the breast.
Topics: Adolescent; Allografts; Bone Marrow Transplantation; Breast; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Graft vs Leukemia Effect; Humans; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sarcoma, Myeloid | 2016 |
18 FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Infant; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2016 |
Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence; Treatment Outcome | 2016 |
Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzofurans; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lymphoma, T-Cell, Peripheral; Positron Emission Tomography Computed Tomography; Recurrence; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2016 |
Interest of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of relapse in patients with spinal infection: a prospective study.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Meningitis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Sensitivity and Specificity; Spinal Diseases | 2016 |
Fluorodeoxyglucose Uptake on Positron Emission Tomography Is a Useful Predictor of Long-Term Pain Control After Palliative Radiation Therapy in Patients With Painful Bone Metastases: Results of a Single-Institute Prospective Study.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pain Management; Palliative Care; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Regression Analysis; Spinal Neoplasms; Time Factors; Tomography, X-Ray Computed | 2016 |
Visual and quantitative comparison of (18)F-fluorodeoxyglucose PET/CT findings in the detection of pelvic tumor recurrence in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; ROC Curve | 2016 |
Extramedullary Involvement of Mast Cell Leukemia Detected by 18F-FDG PET/CT.
Topics: Adolescent; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Mast-Cell; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence | 2016 |
Clinical value of intratumoral metabolic heterogeneity in [18F]FDG PET/CT for prediction of recurrence in patients with locally advanced colorectal cancer.
Topics: Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies | 2018 |
Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Probability; Recurrence; Retrospective Studies; ROC Curve; Skin Neoplasms; Tumor Burden | 2016 |
Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Penile Neoplasms; Positron-Emission Tomography; Prednisone; Recurrence; Rituximab; Tomography, X-Ray Computed; Vincristine | 2016 |
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma.
Topics: Adult; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphocyte Depletion; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Retrospective Studies; Survival Analysis; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2016 |
18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Topics: Adult; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Recurrence; Tumor Burden | 2016 |
Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies | 2016 |
Recurrent surgical site infection of the spine diagnosed by dual (18)F-NaF-bone PET/CT with early-phase scan.
Topics: Adult; C-Reactive Protein; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Surgical Wound Infection | 2016 |
A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Recurrence | 2016 |
Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytogenetic Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Mutation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Topics: Bone Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Patient Care Planning; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Survival Rate | 2017 |
Asymmetric relapse of an HIV-associated Kaposi sarcoma.
Topics: Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Leg; Lymph Nodes; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sarcoma, Kaposi | 2017 |
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Leucovorin; Liver; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Rituximab; Statistics, Nonparametric; Vincristine; Young Adult | 2017 |
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Glycolysis; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Recurrence; Risk; Treatment Outcome; Tumor Burden; Vinblastine | 2017 |
Role of serial F-18 FDG PET/CT scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Remission Induction; Sarcoidosis, Pulmonary; Time Factors; Treatment Outcome | 2016 |
Takayasu's Arteritis with Isolated Pulmonary Artery Involvement in a Middle-Aged Asian Woman with Hepatitis B and Latent Tuberculosis Infection.
Topics: Angiography, Digital Subtraction; Antitubercular Agents; Antiviral Agents; Azathioprine; Female; Fluorodeoxyglucose F18; Glucocorticoids; Guanine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Isoniazid; Latent Tuberculosis; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Recurrence; Stenosis, Pulmonary Artery; Takayasu Arteritis | 2017 |
Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Prognosis; Recurrence; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome | 2017 |
Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Wilms Tumor | 2008 |
Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Aorta; Aorta, Abdominal; Aorta, Thoracic; Aortography; Dilatation, Pathologic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Risk Factors; Sex Factors; Tomography, X-Ray Computed | 2008 |
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Rituximab; Whole Body Imaging | 2008 |
The added benefit of a dedicated neck F-18 FDG PET-CT imaging protocol in patients with suspected recurrent differentiated thyroid carcinoma.
Topics: Carcinoma; Cell Differentiation; Contrast Media; DNA; Fluorodeoxyglucose F18; Humans; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Neoplasms; Whole Body Imaging | 2008 |
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.
Topics: Adolescent; False Negative Reactions; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2008 |
18F FDG-PET/CT findings in recurrent respiratory papillomatosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Papilloma; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed | 2008 |
[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2008 |
Elevated FDG uptake in Kaposi sarcoma mimicking Hodgkin's lymphoma relapse.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Positron-Emission Tomography; Recurrence; Sarcoma, Kaposi; Tomography, X-Ray Computed | 2008 |
High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Rituximab; Sensitivity and Specificity; Survival Analysis; Vincristine; Young Adult | 2009 |
Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Regression, Spontaneous; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome | 2008 |
[Recurrent infective endocarditis. A case report].
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bioprosthesis; Cecal Neoplasms; Colonoscopy; Endocarditis, Bacterial; Enterococcus faecalis; Fluorodeoxyglucose F18; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Opportunistic Infections; Positron-Emission Tomography; Recurrence; Streptococcal Infections; Streptococcus bovis; Streptococcus oralis | 2010 |
Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2009 |
Value of precise localization of recurrent multiple myeloma with F-18 FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2009 |
18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Recurrence; Survival Rate | 2009 |
The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Young Adult | 2009 |
Advanced head and neck cancer: is there a role for fluorodeoxyglucose PET/computed tomography?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
FDG PET/CT findings of splenic angiosarcoma.
Topics: Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Splenic Neoplasms; Tomography, X-Ray Computed | 2009 |
Dual-phase F-18 FDG PET/CT scanning in the suspicion of relapse of ovarian neoplasia.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET-CT imaging in recurrent cerebral gliosarcoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Gliosarcoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2009 |
Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; International Agencies; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
Tl-201 SPECT in clarifying false positive FDG PET findings caused by osteoradionecrosis in a case of nasopharyngeal carcinoma.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Recurrence; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
[67-year-old patient with fever of unkonwn origin, weight loss, night sweats. Takayasu's arteritis].
Topics: Aged; Blood Glucose; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Hyperhidrosis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Takayasu Arteritis; Weight Loss | 2009 |
Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.
Topics: Animals; Antitubercular Agents; Female; Fluorodeoxyglucose F18; Granuloma; Lung; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tuberculosis | 2009 |
Clinical impact of whole body FDG-PET for recurrent biliary cancer: a multicenter study.
Topics: Aged; Aged, 80 and over; Biliary Tract Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Prediction of residual disease of spine infection using F-18 FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Back Pain; Bacterial Infections; Female; Fever; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Intervertebral Disc; Male; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Sensitivity and Specificity; Spinal Cord Compression; Spinal Diseases; Spine; Tomography, X-Ray Computed; Tuberculosis, Spinal; Young Adult | 2009 |
F-18 FDG PET/CT findings in a case of gastric relapse of acute myeloblastic leukemia.
Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
Unusual finding of benign Abrikossoff tumor by F-18 FDG-PET mimicking melanoma recurrence.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Melanoma; Middle Aged; Positron-Emission Tomography; Recurrence | 2009 |
Variable F-18 fluorodeoxyglucose avidity of metastatic recurrent adult granulosa cell tumor.
Topics: Abdominal Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET/CT showing bilateral breast involvement in acute myeloid leukemia relapse.
Topics: Adult; Breast; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Mammography; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
[Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long-term follow-up results].
Topics: Adolescent; Adult; Aged; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Young Adult | 2009 |
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Radionuclide Imaging; Recurrence; Thyroid Neoplasms | 2010 |
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Organ Specificity; Pancreatic Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2010 |
Positron emission tomography and granulosa cell tumor recurrence: a report of 2 cases.
Topics: Aged; Female; Fluorodeoxyglucose F18; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Recurrence | 2009 |
Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features.
Topics: Adult; Aged; Blood Glucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nose Deformities, Acquired; Nose Diseases; Paranasal Sinus Diseases; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Recurrence; Sarcoidosis; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2010 |
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Child; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radionuclide Imaging; Recurrence; Statistics, Nonparametric; Thyroglobulin; Thyroid Neoplasms; Treatment Outcome; Ultrasonography; Whole Body Imaging | 2010 |
F-18 FDG brain PET and Tc-99m ECD brain SPECT in a patient with multiple recurrent epileptic seizures.
Topics: Brain; Cysteine; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Organotechnetium Compounds; Positron-Emission Tomography; Recurrence; Tomography, Emission-Computed, Single-Photon | 2010 |
Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Recurrence; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Comparison of positron emission tomography with [(18)F]FDG and [(68)Ga]DOTATOC in recurrent differentiated thyroid cancer: preliminary data.
Topics: Adult; Aged; Aged, 80 and over; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Recurrence; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2010 |
Perineural recurrence of buccal cancer demonstrated by F-18 FDG PET/CT.
Topics: Cheek; Facial Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peripheral Nerves; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2010 |
F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Polyradiculopathy; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2010 |
FDG positron emission tomography/computed tomography studies of Wilms' tumor.
Topics: Adolescent; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Wilms Tumor; Young Adult | 2010 |
Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Endoscopy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Physical Examination; Positron-Emission Tomography; Postoperative Period; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
A rare cause of fever and PET-positive nodules in the lungs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bronchoscopy; Female; Fever; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Lymphomatoid Granulomatosis; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Role of FDG-PET/CT in detection of recurrent disease in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Young Adult | 2010 |
Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
Topics: Chemotherapy, Adjuvant; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Gynecologic Surgical Procedures; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Registries; Risk Assessment; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer.
Topics: Adult; Aged; Calcitonin; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Young Adult | 2010 |
Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2010 |
Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Tyrosine | 2010 |
Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Postoperative Period; Prognosis; Recurrence; Retrospective Studies; Risk; Vascular Endothelial Growth Factor D | 2010 |
F-18 FDG PET/CT in the assessment of recurrent anaplastic T-cell lymphoma of the external auditory canal.
Topics: Ear Canal; Ear Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2010 |
Role of FDG-PET in the definition of involved-field radiation therapy and management for pediatric Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed | 2011 |
Role of FDG PET-CT in recurrent renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2010 |
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transp
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Graft vs Host Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2010 |
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Contrast Media; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Liver; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Recurrence; Spleen; Tomography, X-Ray Computed; Young Adult | 2011 |
Chest wall and axillary lymph node FDG uptake associated with cancer vaccine therapy for lung cancer.
Topics: Aged; Axilla; Cancer Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Positron-Emission Tomography; Recurrence; Small Cell Lung Carcinoma; Thoracic Wall; Tomography, X-Ray Computed | 2010 |
The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Remission Induction; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
Comparison of 18F-FDG and 11C-choline PET/CT for detecting recurrences in patients with nonsquamous cell head and neck malignancies.
Topics: Biological Transport; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Colovesical fistula in a patient with recurrent cervical cancer detected by FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Fistula; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Post-treatment [¹⁸F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?
Topics: Adult; Aged; Decision Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Fluorodeoxyglucose F18; Gemcitabine; Hodgkin Disease; Humans; Positron-Emission Tomography; Recurrence; Research Report; Retrospective Studies; Survival Analysis; Vinblastine; Vinorelbine | 2010 |
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence; Tomography, X-Ray Computed | 2011 |
A case of localized IgG4-related thoracic periarteritis and recurrent nerve palsy.
Topics: Adult; Aorta, Thoracic; Arteritis; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Male; Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2011 |
F-18 FDG-PET/CT in aseptic abscesses with recurrent febrile abdominal pain.
Topics: Abdominal Abscess; Abdominal Pain; Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclophosphamide; Female; Fever; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hereditary Autoinflammatory Diseases; Humans; Immunosuppressive Agents; Liver Diseases; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Recurrence; Spleen | 2011 |
The impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalities.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
FDG PET/CT evaluation of treatment response in patients with recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Incidental finding of F-18 FDG skin uptake in a patient with psoriasis during the evaluation of a recurrent papillary thyroid carcinoma.
Topics: Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Psoriasis; Recurrence; Skin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Utility of ¹¹C-choline imaging as a supplement to F-18 FDG PET imaging for detection of thyroid carcinoma.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results.
Topics: Bombesin; Discriminant Analysis; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Positron-Emission Tomography; Recurrence | 2011 |
The local efficacy of I-131 for F-18 FDG PET positive lesions in patients with recurrent or metastatic thyroid carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Thyroid Neoplasms; Treatment Outcome; Tumor Burden; Young Adult | 2011 |
Long-term survival in a patient with node-positive adult-onset Xp11.2 translocation renal cell carcinoma.
Topics: Adult; Carcinoma, Renal Cell; Chromosome Aberrations; Chromosomes, Human, X; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Nodes; Nephrectomy; Radiopharmaceuticals; Recurrence; Translocation, Genetic; Treatment Outcome | 2011 |
Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Survival Analysis; Uterine Cervical Neoplasms | 2011 |
Malignant perivascular epithelioid cell tumor (PEComa) of the uterus: serial imaging with F-18 FDG PET/CT for surveillance of recurrence and evaluation of response to therapy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Perivascular Epithelioid Cell Neoplasms; Positron-Emission Tomography; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms | 2011 |
F-18 FDG PET/CT imaging of solitary genital tuberculosis mimicking recurrent lymphoma.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Tuberculosis, Male Genital | 2011 |
Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study.
Topics: Adult; Benzimidazoles; Echinococcosis; Echinococcosis, Hepatic; End Stage Liver Disease; Female; Fluorodeoxyglucose F18; Humans; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Improved prognostic value of standardized uptake value corrected for blood glucose level in pancreatic cancer using F-18 FDG PET.
Topics: Adult; Aged; Biological Transport; Blood Glucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2011 |
Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2011 |
Could the serial determination of Ca15.3 serum improve the diagnostic accuracy of PET/CT?: results from small population with previous breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Blood Chemical Analysis; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
False-positive positron emission tomography in patients with history of malignancy.
Topics: Adult; Anus Neoplasms; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma, Lobular; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Characteristics of autoimmune pancreatitis based on serum IgG4 level.
Topics: Aged; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Biomarkers; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Jaundice; Male; Middle Aged; Multidetector Computed Tomography; Pancreatitis; Positron-Emission Tomography; Prednisolone; Recurrence; Statistics, Nonparametric; Ultrasonography | 2011 |
Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Recurrence; Salvage Therapy; Transplantation, Autologous; Young Adult | 2011 |
Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Adenocarcinoma, Mucinous; Adult; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Inflammation; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence | 2011 |
Extramedullary gastric relapse of acute lymphoblastic leukemia following allogeneic stem cell transplant: staging with F-18 FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stem Cell Transplantation; Stomach Neoplasms; Tomography, X-Ray Computed; Transplantation, Homologous | 2011 |
False-positive PET/CT for lymphoma recurrence secondary to Langerhans cell histiocytosis.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Lymphoma; Male; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2011 |
Recurrent ovarian carcinoma presenting as a solitary sternal metastasis on FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Sternum; Thoracic Neoplasms; Tomography, X-Ray Computed | 2011 |
Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Survival Rate; Uterine Cervical Neoplasms | 2011 |
False positive fixation of fluorodeoxyglucose positron emission tomography after correction of a vocal cord paralysis.
Topics: Dimethylpolysiloxanes; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Prostheses and Implants; Radiopharmaceuticals; Recurrence; Vocal Cord Paralysis | 2011 |
Underperformance of gallium-67 scan is greater in relapse than in initial staging, compared with FDG PET.
Topics: Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Male; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Whole Body Imaging | 2011 |
Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hemoglobins; Humans; Male; Middle Aged; Multivariate Analysis; Oropharyngeal Neoplasms; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy; Recurrence; Retrospective Studies; Treatment Outcome | 2011 |
Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Topics: Adult; Aged; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Hydronephrosis caused by a relapse of granulomatosis with polyangiitis (Wegener's).
Topics: Aged; Cyclophosphamide; Drug Therapy, Combination; Fluorodeoxyglucose F18; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Hydronephrosis; Immunosuppressive Agents; Male; Methylprednisolone; Microscopic Polyangiitis; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2012 |
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy.
Topics: Aged; Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kinetics; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Recurrence; Time Factors; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Reference Standards; Reproducibility of Results; Retrospective Studies; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous | 2012 |
Neurolymphomatosis: role of positron emission tomography in diagnosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Recurrence; Uterine Cervical Neoplasms | 2012 |
Umbilical metastatic deposit from recurrent cholangiocarcinoma: F18-FDG PET-CT findings.
Topics: Aged; Cholangiocarcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Recurrence; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Umbilicus | 2011 |
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Recurrence; Retrospective Studies; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.
Topics: Adult; Aged; Biological Transport; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts.
Topics: Cohort Studies; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prognosis; Recurrence; Registries; Treatment Outcome | 2012 |
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence.
Topics: Aged; Carotid Stenosis; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Stroke; Tomography, X-Ray Computed | 2012 |
High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methylprednisolone; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2013 |
Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Retrospective Studies; ROC Curve; Severity of Illness Index; Takayasu Arteritis; Tomography, X-Ray Computed; Young Adult | 2012 |
The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Carcinoma endometrium: role of 18-FDG PET/CT for detection of suspected recurrence.
Topics: Adenocarcinoma; Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2012 |
Asymptomatic metastasis to the larynx detected by FDG PET/CT in a patient with recurrent rectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2012 |
18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
Topics: Adenocarcinoma; Adult; Aged; Asia; Asian People; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Reference Standards; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma.
Topics: Adult; Aged; Aged, 80 and over; Esthesioneuroblastoma, Olfactory; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms; Whole Body Imaging | 2012 |
Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities.
Topics: CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2012 |
Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiography, Abdominal; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Recurrent glioma and crossed cerebellar diaschisis in a patient examined with 18F-DOPA and 18F-FDG PET/CT.
Topics: Cerebellar Diseases; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Middle Aged; Radionuclide Imaging; Recurrence | 2012 |
18F-FDG PET/CT diagnosis of vagus nerve neurolymphomatosis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Multimodal Imaging; Neoplasms, Nerve Tissue; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Vagus Nerve Diseases | 2012 |
Pediatric epilepsy surgery: long-term 5-year seizure remission and medication use.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Cohort Studies; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Infant; Logistic Models; Magnetic Resonance Imaging; Male; Pediatrics; Positron-Emission Tomography; Recurrence; Time Factors; Treatment Outcome | 2012 |
Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT.
Topics: Biopsy, Fine-Needle; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2013 |
Vesicovaginorectal fistula on a FDG PET/CT of a patient with recurrent cervical cancer and end-stage renal disease.
Topics: Female; Fluorodeoxyglucose F18; Humans; Kidney Failure, Chronic; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Rectal Fistula; Recurrence; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Fistula | 2012 |
An atypical relapse of acute myeloid leukemia diagnosed by 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2012 |
Seizure worsening and its predictors after epilepsy surgery.
Topics: Adolescent; Adult; Cohort Studies; Death, Sudden; Electroencephalography; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Recurrence; Retrospective Studies; Seizures; Time Factors; Tomography, Emission-Computed, Single-Photon; Young Adult | 2012 |
Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for localizing recurrence in patients with differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography; Whole Body Imaging | 2012 |
Primary gastric lymphoma: utility of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for detecting relapse after treatment.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Young Adult | 2012 |
Serologic factors in early relapse of IgG4-related orbital inflammation after steroid treatment.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Cohort Studies; Female; Flow Cytometry; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glucocorticoids; Humans; Immunoglobulin G; Male; Middle Aged; Orbital Pseudotumor; Positron-Emission Tomography; Receptors, Interleukin-2; Recurrence; Retrospective Studies; Rheumatoid Factor; Tomography, X-Ray Computed | 2013 |
A retrospective study comparing contrast-enhanced computed tomography with 18F-FDG-PET/CT in the early follow-up of patients with retroperitoneal sarcomas.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retroperitoneal Neoplasms; Retrospective Studies; Sarcoma; Time Factors; Tomography, X-Ray Computed | 2013 |
ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiation Monitoring; Radiography; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Young Adult | 2013 |
A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Stem Cell Transplantation; Treatment Outcome; Young Adult | 2013 |
Abdominal aortic aneurysm with bony erosion mimicking recurrent non-Hodgkin lymphoma on FDG PET/CT.
Topics: Aged, 80 and over; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2013 |
Optimal timing of post-treatment [18F]fluorodeoxyglucose-PET/CT for patients with head and neck malignancy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Circumferential resection margin involvement in stage III rectal cancer patients treated with curative resection followed by chemoradiotherapy: a surrogate marker for local recurrence?
Topics: Aged; Biomarkers; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Rectal Neoplasms; Recurrence; Surgical Procedures, Operative; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Recurrence; Tomography, X-Ray Computed | 2013 |
Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Topics: Aged; Aged, 80 and over; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Fibrosis; Radiation Injuries; Radiosurgery; Recurrence; Tomography, X-Ray Computed | 2013 |
The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Antigens, Helminth; Benzimidazoles; Child; Child, Preschool; Echinococcosis; Echinococcosis, Hepatic; Echinococcus; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Time Factors; Young Adult | 2013 |
Cardiac and acoustic metastases in relapsing melanoma.
Topics: Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Melanoma; Middle Aged; Neuroma, Acoustic; Radionuclide Imaging; Recurrence | 2013 |
[Initial experiences with adjuvant locoregional radioimmunotherapy using 131I-labeled monoclonal antibodies against tenascin (BC-4) for treatment of glioma (WHO III and IV)].
Topics: Adult; Aged; Antibodies, Monoclonal; Brain Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Iodine Radioisotopes; Male; Middle Aged; Radioimmunotherapy; Radioisotopes; Recurrence; Survival Analysis; Tenascin; Time Factors; Tomography, Emission-Computed | 2002 |
Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Recurrence; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.
Topics: Adult; Aged; Disease Progression; Extremities; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lymph Nodes; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2002 |
18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasms; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Skin Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Whole-body (18)F-FDG PET identifies high-risk myeloma.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Plasmacytoma; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Utility of FDG-PET scanning in lymphoma by WHO classification.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[18F-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer].
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Evidence-Based Medicine; Fluorodeoxyglucose F18; Germany; Humans; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, Emission-Computed | 2003 |
Predictive value of early 18F-fluoro-deoxyglucose positron emission tomography in chemosensitive relapsed lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Stem Cell Transplantation; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia.
Topics: Adult; Biopsy; Bone Marrow; Bones of Upper Extremity; Female; Fluorodeoxyglucose F18; Humans; Humerus; Ilium; Leg Bones; Magnetic Resonance Imaging; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tomography, Emission-Computed; Transplantation, Homologous | 2004 |
Remitting/relapsing idiopathic hypertrophic spinal pachymeningitidis: comprehensive imaging work-up and MR monitoring.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hypertrophy; Magnetic Resonance Imaging; Meningitis; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed | 2005 |
The influence of CA 125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer.
Topics: Biomarkers, Tumor; CA-125 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Recurrence; Reference Values; Retrospective Studies | 2004 |
Endometriosis with FDG uptake on PET.
Topics: Abdominal Pain; Adult; CA-125 Antigen; Endometriosis; Endosonography; Female; Fluorodeoxyglucose F18; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Hormones; Humans; Laparoscopy; Magnetic Resonance Imaging; Pelvic Pain; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Reoperation; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Mediastinal bulky tumour in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post-treatment residual masses.
Topics: Child; Child, Preschool; Diagnostic Errors; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Male; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Rate | 2004 |
18FDG-PET in 733 consecutive patients with or without side-by-side CT evaluation: analysis of 921 lesions.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed | 2004 |
[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Adult; Carcinoid Tumor; Corticotropin-Releasing Hormone; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Paraneoplastic Endocrine Syndromes; Positron-Emission Tomography; Recurrence; Thymectomy; Thymus Neoplasms | 2005 |
Pancreatic neuroendocrine tumor with portal vein tumor thrombus: PET demonstration.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Neuroendocrine Tumors; Pancreatic Neoplasms; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Venous Thrombosis | 2005 |
Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity | 2005 |
Vasculitis of the aortic arch and cardiac valves as the cause of relapsing fever of unknown origin in an elderly, white man.
Topics: Aged; Aorta, Thoracic; Fever of Unknown Origin; Fluorodeoxyglucose F18; Heart Valves; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Time Factors; Vasculitis; White People | 2006 |
Primary skeletal muscle marginal zone lymphoma with persistent tissue tropism and PET-avidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Prednisone; Recurrence; Remission Induction; Sensitivity and Specificity; Vincristine | 2006 |
(18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies.
Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma.
Topics: Adolescent; Child; Child, Preschool; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity | 2006 |
Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence.
Topics: Adult; Aged; Animals; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Microvessels; Middle Aged; Patient Selection; Positron-Emission Tomography; Recurrence; Regression Analysis; Sensitivity and Specificity; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2006 |
Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer.
Topics: Antigens, Neoplasm; Documentation; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Salvage Therapy; Sensitivity and Specificity; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2006 |
PET positive progressive transformation of germinal centers masquerading as relapsed Hodgkin lymphoma post-autograft.
Topics: Cell Transformation, Neoplastic; Diagnosis, Differential; Fluorodeoxyglucose F18; Germinal Center; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Remission Induction; Transplantation, Autologous | 2006 |
Combined increased and decreased skeletal uptake of F-18 FDG.
Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Thoracic Vertebrae; Tomography, X-Ray Computed | 2006 |
Pitfalls of positron emission tomography for assessing relapse in Hodgkin's disease: a case report.
Topics: Contraindications; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2006 |
Unsuspected FDG-PET findings in the follow-up of patients with lymphoma.
Topics: Aged; Biopsy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Infections; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Recurrence; Retrospective Studies | 2007 |
[The value of FDG-PET/CT in the evaluation of patients with a pulmonary nodule and a previous malignant disease].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Solitary Pulmonary Nodule; Tomography, Emission-Computed, Single-Photon | 2006 |
18F-Flourodeoxyglucose positron emission tomography in polymyalgia rheumatica: novel insight into complex pathogenesis but questionable use in predicting relapses.
Topics: Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence | 2007 |
Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients.
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hip; Humans; Male; Methylprednisolone; Middle Aged; Polymyalgia Rheumatica; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Severity of Illness Index; Shoulder; Spine; Subclavian Artery | 2007 |
Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Retrospective Studies | 2007 |
Hypermetabolic change as a possible predictive sign of a relapsed central nervous system lymphoma.
Topics: Central Nervous System Neoplasms; Dysarthria; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Recurrence | 2007 |
Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
Topics: Adolescent; Adult; Aged; Choristoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Male; Mediastinal Diseases; Mediastinum; Middle Aged; Myasthenia Gravis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Thymoma; Thymus Gland; Thymus Neoplasms; Tomography, X-Ray Computed | 2007 |
Non-Hodgkin's lymphoma of the bone can mimic osteomyelitis on FDG PET.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Osteomyelitis; Radiopharmaceuticals; Recurrence; Tibia; Tomography, Emission-Computed | 2007 |
Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma.
Topics: Adult; Antineoplastic Agents; CA-125 Antigen; Cisplatin; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Reproducibility of Results; Whole Body Imaging | 2007 |
PET monitoring of clear cell sarcoma of tendons and aponeuroses.
Topics: Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Sarcoma, Clear Cell; Soft Tissue Neoplasms; Tendons; Tomography, X-Ray Computed | 2007 |
Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma.
Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Recurrence; Remission Induction; Treatment Failure; Valproic Acid | 2007 |
Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Topics: Adolescent; Adult; Aged; Biopsy; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Data Collection; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2007 |
Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management.
Topics: Adult; Bone Neoplasms; Female; Fibroma; Fibromatosis, Abdominal; Fluorodeoxyglucose F18; Gardner Syndrome; Humans; Male; Muscle Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2007 |
Case records of the Massachusetts General Hospital. Case 26-2007 - a 61-year-old man with recurrent fevers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Duodenum; Fever; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiography; Recurrence; Renal Insufficiency; Salvage Therapy; Vascular Neoplasms; Vincristine | 2007 |
A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Castleman Disease; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Hyalin; Immunologic Factors; Plasma Cells; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
[Usefulness of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in diagnosis and treatment of pelvic recurrence of bladder cancer after radical cystectomy: a case report].
Topics: Carcinoma; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2007 |
Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2007 |
PET versus PET-CT in patient with suspicion of non-Hodgkin lymphoma recurrence.
Topics: Aneurysm, Infected; Aneurysm, Ruptured; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2007 |
Systemic lupus erythematosus complicated with aortitis.
Topics: Aortitis; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Treatment Outcome | 2008 |
Role of FDG-PET in the assessment of survival prognosis in melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Time Factors; Tomography, Spiral Computed | 2007 |
[Reversible hypogeusia during bilateral thalamic stimulation for essential tremor].
Topics: Ageusia; Basal Ganglia; Blood Glucose; Brain Mapping; Cerebral Cortex; Deep Brain Stimulation; Dysgeusia; Essential Tremor; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Positron-Emission Tomography; Recurrence; Ventral Thalamic Nuclei | 2008 |
Elucidation of acute renal failure due to recurrent non-Hodgkin lymphoma by F-18 FDG PET/CT.
Topics: Acute Kidney Injury; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Recurrence; Risk Factors | 2008 |
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Transplantation, Autologous | 2008 |
Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC).
Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Neoplasm Staging; Organizations; Phantoms, Imaging; Positron-Emission Tomography; Prognosis; Recurrence; Survival Rate | 2008 |
Visualization of pericarditis with fluoro-deoxy-glucose-positron emission tomography/computed tomography.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Pericarditis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sclerosis | 2008 |
FDG PET and evaluation of posttherapeutic residual tumors in pediatric oncology: preliminary experience.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Retrospective Studies; Treatment Outcome | 2008 |
Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; False Positive Reactions; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Recurrence; Reproducibility of Results; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Brain Neoplasms; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiotherapy; Radiotherapy Dosage; Recurrence; Stereotaxic Techniques; Tomography, Emission-Computed | 1993 |
PET imaging of recurrent medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Recurrence; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1996 |
[18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results].
Topics: Adult; Aged; Cystadenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
[Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Regression Analysis; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
[Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
PET evaluation of therapeutic limb perfusion in Merkel's cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Carcinoma, Merkel Cell; Chemotherapy, Cancer, Regional Perfusion; Female; Fluorodeoxyglucose F18; Humans; Leg; Melphalan; Radiopharmaceuticals; Recurrence; Skin Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha | 1998 |
Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adult; Carcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Recurrence; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1998 |
F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Middle Aged; Neoplasms; Phantoms, Imaging; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Topics: Adult; Astrocytoma; Brain; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Necrosis; Oligodendroglioma; Pilot Projects; Radiation Injuries; Radiography; Radiopharmaceuticals; Radiotherapy; Recurrence; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Fluorine-18 fluorodeoxyglucose dual-head positron emission tomography in the detection of recurrent differentiated thyroid cancer: preliminary results.
Topics: Adult; Aged; Cell Differentiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Recurrence; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
[Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma.
Topics: Adult; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Recombinant Proteins; Recurrence; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Tomography, Emission-Computed | 2001 |
[F-18-FDG PET for the detection of aggressive fibromatosis].
Topics: Adult; Female; Fibromatosis, Aggressive; Fluorodeoxyglucose F18; Humans; Prednisolone; Radiopharmaceuticals; Recurrence; Thyroiditis, Autoimmune; Tomography, Emission-Computed | 2000 |
18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT.
Topics: Adult; Age Factors; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Spleen; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Necrosis; Radiography; Radiosurgery; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
Topics: Adenocarcinoma, Follicular; Brain Neoplasms; Carcinoma, Papillary; Databases as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Magnetic Resonance Imaging; MEDLINE; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Patient Selection; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2001 |
FDG PET for evaluating breast cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Breast Neoplasms; Device Approval; Drug Approval; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2001 |
[[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Is an FDG-PET scan the new imaging standard for colon cancer?
Topics: Carcinoembryonic Antigen; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Laparotomy; Radiopharmaceuticals; Recurrence; Second-Look Surgery; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen le
Topics: Adult; Aged; Antibodies, Monoclonal; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Male; Middle Aged; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Recurrence; Second-Look Surgery; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recurrence; Tomography, Emission-Computed | 2001 |
Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate.
Topics: Activities of Daily Living; Adult; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Chronic Disease; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Prognosis; Psychiatric Status Rating Scales; Recurrence; Reference Values; Schizophrenia; Tomography, Emission-Computed; Verbal Learning | 2002 |
Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiography; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed | 2002 |
[PET scan in patients with epipharyngeal tumors].
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |